Review
. 2007 Oct;25(33).
doi: 10.1200/JCO.2007.14.2364.

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

Lyndsay Harris 1 Herbert Fritsche  Robert Mennel  Larry Norton  Peter Ravdin  Sheila Taube  Mark R Somerfield  Daniel F Hayes  Robert C Bast  American Society of Clinical Oncology  
Affiliations
  • PMID: 17954709
  •     704 citations

Abstract

Purpose: To update the recommendations for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of breast cancer.

Methods: For the 2007 update, an Update Committee composed of members from the full Panel was formed to complete the review and analysis of data published since 1999. Computerized literature searches of MEDLINE and the Cochrane Collaboration Library were performed. The Update Committee's literature review focused attention on available systematic reviews and meta-analyses of published tumor marker studies. In general, significant health outcomes (overall survival, disease-free survival, quality of life, lesser toxicity, and cost-effectiveness) were used for making recommendations. Recommendations and

Conclusions: Thirteen categories of breast tumor markers were considered, six of which were new for the guideline. The following categories showed evidence of clinical utility and were recommended for use in practice: CA 15-3, CA 27.29, carcinoembryonic antigen, estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, urokinase plasminogen activator, plasminogen activator inhibitor 1, and certain multiparameter gene expression assays. Not all applications for these markers were supported, however. The following categories demonstrated insufficient evidence to support routine use in clinical practice: DNA/ploidy by flow cytometry, p53, cathepsin D, cyclin E, proteomics, certain multiparameter assays, detection of bone marrow micrometastases, and circulating tumor cells.

Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues.
A Vincent-Salomon, F C Bidard, J Y Pierga.
J Clin Pathol, 2007 Nov 27; 61(5). PMID: 18037661    Free PMC article.
Review.
Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer.
Karen S Anderson, Niroshan Ramachandran, +9 authors, Joshua LaBaer.
J Proteome Res, 2008 Mar 04; 7(4). PMID: 18311903    Free PMC article.
Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer?
S Bahri, J-H Chen, +3 authors, M-Y Su.
Ann Oncol, 2008 Mar 08; 19(4). PMID: 18325916    Free PMC article.
Cathepsin D--many functions of one aspartic protease.
Petr Benes, Vaclav Vetvicka, Martin Fusek.
Crit Rev Oncol Hematol, 2008 Apr 09; 68(1). PMID: 18396408    Free PMC article.
Highly Cited. Review.
Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists.
Jonathan D Mosley, Ruth A Keri.
BMC Med Genomics, 2008 Apr 29; 1. PMID: 18439262    Free PMC article.
A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients?
Daniel F Hayes, Vered Stearns, +2 authors, Consortium on Breast Cancer Pharmacogenomics.
J Natl Cancer Inst, 2008 May 01; 100(9). PMID: 18445818    Free PMC article.
Unraveling the microenvironmental influences on the normal mammary gland and breast cancer.
Britta Weigelt, Mina J Bissell.
Semin Cancer Biol, 2008 May 06; 18(5). PMID: 18455428    Free PMC article.
Highly Cited. Review.
Autoantibodies as potential biomarkers for breast cancer.
Li Zhong, Kun Ge, +8 authors, Kemp H Kernstine.
Breast Cancer Res, 2008 May 08; 10(3). PMID: 18460216    Free PMC article.
Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer.
Kan Yonemori, Noriyuki Katsumata, +9 authors, Yasuhiro Fujiwara.
J Cancer Res Clin Oncol, 2008 Jun 06; 134(11). PMID: 18528707
Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression.
David P Turner, Victoria J Findlay, +2 authors, Dennis K Watson.
Mol Biol Cell, 2008 Jun 27; 19(9). PMID: 18579687    Free PMC article.
Circulating tumor cells in breast cancer: methodology and clinical repercussions.
J M Gasent Blesa, V Alberola Candel, +5 authors, K Pachmann.
Clin Transl Oncol, 2008 Jul 17; 10(7). PMID: 18628068
Review.
Plasminogen activator inhibitor 1 protects fibrosarcoma cells from etoposide-induced apoptosis through activation of the PI3K/Akt cell survival pathway.
Maria U Rømer, Lise Larsen, +2 authors, Ulrik A Lademann.
Neoplasia, 2008 Sep 25; 10(10). PMID: 18813358    Free PMC article.
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
Golareh Habibi, Samuel Leung, +7 authors, Sandra E Dunn.
Breast Cancer Res, 2008 Oct 18; 10(5). PMID: 18925950    Free PMC article.
Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer.
Masahiro Uehara, Takayuki Kinoshita, +3 authors, Takashi Fukutomi.
Int J Clin Oncol, 2008 Oct 24; 13(5). PMID: 18946756
Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse.
François-Clément Bidard, Anne Vincent-Salomon, +6 authors, Jean-Yves Pierga.
Clin Exp Metastasis, 2008 Nov 08; 25(8). PMID: 18989740
Molecular imaging as a tool for translating breast cancer science.
David A Mankoff.
Breast Cancer Res, 2009 Jan 06; 10 Suppl 1. PMID: 19091007    Free PMC article.
Review.
Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer.
Shigeto Ueda, Nobuo Kondoh, +10 authors, Hidetaka Mochizuki.
BMC Cancer, 2008 Dec 24; 8. PMID: 19102762    Free PMC article.
Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.
Genet Med, 2009 Jan 07; 11(1). PMID: 19125125    Free PMC article.
Markers of endocrine sensitivity.
Daniel F Hayes.
Breast Cancer Res, 2009 Jan 16; 10 Suppl 4. PMID: 19128431    Free PMC article.
Pharmacogenetics and pharmacogenomics of anticancer agents.
R Stephanie Huang, Mark J Ratain.
CA Cancer J Clin, 2009 Jan 17; 59(1). PMID: 19147868    Free PMC article.
Review.
Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients.
J G H van Nes, V T H B M Smit, +11 authors, C J H van de Velde.
Br J Cancer, 2009 Jan 22; 100(3). PMID: 19156146    Free PMC article.
[Prognostic and predictive factors of invasive breast cancer: update 2009].
T Decker, D Hungermann, W Böcker.
Pathologe, 2009 Feb 03; 30(1). PMID: 19184022
Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
Natasa Snoj, Philippe L Bedard, +2 authors, Martine Piccart.
Breast Cancer Res, 2009 Feb 17; 11(1). PMID: 19216727    Free PMC article.
Review.
[Genome-wide expression profiling as a clinical tool: are we there yet?].
F C Geyer, T Decker, J S Reis-Filho.
Pathologe, 2009 Feb 17; 30(2). PMID: 19219435
Review.
A single-tube quantitative assay for mRNA levels of hormonal and growth factor receptors in breast cancer specimens.
Ayuko A Iverson, Cheryl Gillett, +12 authors, Sheng-Yung P Chang.
J Mol Diagn, 2009 Feb 20; 11(2). PMID: 19225135    Free PMC article.
A radiation-derived gene expression signature predicts clinical outcome for breast cancer patients.
Brian D Piening, Pei Wang, Aravind Subramanian, Amanda G Paulovich.
Radiat Res, 2009 Mar 10; 171(2). PMID: 19267539    Free PMC article.
Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer.
Vathany Kulasingam, Yingye Zheng, +3 authors, Eleftherios P Diamandis.
Int J Cancer, 2009 Mar 27; 125(1). PMID: 19322904    Free PMC article.
Bringing diagnostic technologies to the clinical laboratory: Rigor, regulation, and reality.
Gordon Whiteley.
Proteomics Clin Appl, 2008 Jan 01; 2(10-11). PMID: 19325937    Free PMC article.
Systems pharmacology and genome medicine: a future perspective.
Aislyn D Wist, Seth I Berger, Ravi Iyengar.
Genome Med, 2009 Apr 08; 1(1). PMID: 19348698    Free PMC article.
The role of the calcium-sensing receptor in bone biology and pathophysiology.
T A Theman, M T Collins.
Curr Pharm Biotechnol, 2009 Apr 10; 10(3). PMID: 19355939    Free PMC article.
Review.
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond.
R D Riley, W Sauerbrei, D G Altman.
Br J Cancer, 2009 Apr 16; 100(8). PMID: 19367280    Free PMC article.
Review.
Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET.
Mark P S Dunphy, Jason S Lewis.
J Nucl Med, 2009 Apr 22; 50 Suppl 1. PMID: 19380404    Free PMC article.
Review.
Molecular aspects of tumour hypoxia.
Saskia E Rademakers, Paul N Span, +3 authors, Johan Bussink.
Mol Oncol, 2009 Apr 23; 2(1). PMID: 19383328    Free PMC article.
Review.
Biomarkers in oncology drug development.
Darren R Hodgson, Robin D Whittaker, +2 authors, Glen Clack.
Mol Oncol, 2009 Apr 23; 3(1). PMID: 19383364    Free PMC article.
Review.
Cancer micrometastases.
Klaus Pantel, Catherine Alix-Panabières, Sabine Riethdorf.
Nat Rev Clin Oncol, 2009 Apr 29; 6(6). PMID: 19399023
Highly Cited. Review.
In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.
Anne E Lykkesfeldt, Katrine L Henriksen, +5 authors, Henning T Mouridsen.
BMC Cancer, 2009 Jun 18; 9. PMID: 19531212    Free PMC article.
Intrinsic bias in breast cancer gene expression data sets.
Jonathan D Mosley, Ruth A Keri.
BMC Cancer, 2009 Jul 01; 9. PMID: 19563679    Free PMC article.
Nano-bio-chips for high performance multiplexed protein detection: determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels.
Jesse V Jokerst, Archana Raamanathan, +8 authors, John T McDevitt.
Biosens Bioelectron, 2009 Jul 07; 24(12). PMID: 19576756    Free PMC article.
Current molecular diagnostics of breast cancer and the potential incorporation of microRNA.
Christine K Zoon, Elizabeth Q Starker, +3 authors, Michael A Tangrea.
Expert Rev Mol Diagn, 2009 Jul 08; 9(5). PMID: 19580430    Free PMC article.
Review.
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.
C Liedtke, K Broglio, +11 authors, A M Gonzalez-Angulo.
Ann Oncol, 2009 Jul 15; 20(12). PMID: 19596702    Free PMC article.
Highly Cited.
MicroRNAs as Novel Biomarkers for Breast Cancer.
H M Heneghan, N Miller, +2 authors, M J Kerin.
J Oncol, 2009 Jul 30; 2009. PMID: 19639033    Free PMC article.
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
Fatima Cardoso, Philippe L Bedard, +8 authors, ESO-MBC Task Force.
J Natl Cancer Inst, 2009 Aug 07; 101(17). PMID: 19657108    Free PMC article.
Review.
Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.
Ji-Yeob Choi, William E Barlow, +14 authors, Christine B Ambrosone.
Clin Cancer Res, 2009 Aug 13; 15(16). PMID: 19671875    Free PMC article.
Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study.
Anne-Sofie Schrohl, Maxime P Look, +2 authors, Nils Brünner.
BMC Cancer, 2009 Sep 12; 9. PMID: 19744322    Free PMC article.
Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients.
A Kulić, M Sirotković-Skerlev, +3 authors, D Vrbanec.
Med Oncol, 2009 Sep 19; 27(3). PMID: 19763913
Serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of diagnosis.
Didem S Dede, Cagatay Arslan, Kadri Altundag.
Med Oncol, 2009 Sep 24; 27(4). PMID: 19774500
Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma.
N S Vasudev, S Sim, +7 authors, R E Banks.
Br J Cancer, 2009 Oct 01; 101(7). PMID: 19789534    Free PMC article.
Use of archived specimens in evaluation of prognostic and predictive biomarkers.
Richard M Simon, Soonmyung Paik, Daniel F Hayes.
J Natl Cancer Inst, 2009 Oct 10; 101(21). PMID: 19815849    Free PMC article.
Highly Cited.
Urokinase expression in course of benign and malignant mammary lesions: comparison between nodular and healthy tissues.
Francesca Ceccarelli, Andrea Fuso, +5 authors, Sigfrido Scarpa.
J Cancer Res Clin Oncol, 2009 Oct 15; 136(1). PMID: 19826838
Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells.
Manfred Schmitt, John A Foekens.
Breast Cancer Res, 2009 Oct 17; 11(5). PMID: 19833005    Free PMC article.
Salivary protein factors are elevated in breast cancer patients.
Mai N Brooks, Jianghua Wang, +3 authors, David T Wong.
Mol Med Rep, 2008 Jan 01; 1(3). PMID: 19844594    Free PMC article.
Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index.
Mu-Tai Liu, Wen-Tao Huang, +5 authors, Hao-Han Yang.
Support Care Cancer, 2009 Nov 12; 18(12). PMID: 19904562
Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology.
Daniel E Abbott, Naira V Margaryan, +7 authors, Mary J C Hendrix.
Cancer Biol Ther, 2009 Nov 20; 9(1). PMID: 19923884    Free PMC article.
[Beyond staging, typing and grading. New challenges in breast cancer pathology].
H H Kreipe, P Ahrens, +2 authors, F Länger.
Pathologe, 2009 Dec 02; 31(1). PMID: 19949797
Review.
Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer.
Philippe L Bedard, Angelo Di Leo, Martine J Piccart-Gebhart.
Nat Rev Clin Oncol, 2009 Dec 10; 7(1). PMID: 19997076
Review.
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Kathy S Albain, William E Barlow, +20 authors, Breast Cancer Intergroup of North America.
Lancet Oncol, 2009 Dec 17; 11(1). PMID: 20005174    Free PMC article.
Highly Cited.
Genomic markers for decision making: what is preventing us from using markers?
Vicky M Coyle, Patrick G Johnston.
Nat Rev Clin Oncol, 2009 Dec 17; 7(2). PMID: 20010899
Review.
PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer.
G Munkácsy, R Abdul-Ghani, +5 authors, B Györffy.
Br J Cancer, 2009 Dec 17; 102(2). PMID: 20010949    Free PMC article.
Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients.
Sabine Riethdorf, Klaus Pantel.
Breast Cancer Res, 2010 Jan 20; 11 Suppl 3. PMID: 20030861    Free PMC article.
Circulating tumor cell analysis: technical and statistical considerations for application to the clinic.
Alison L Allan, Michael Keeney.
J Oncol, 2010 Jan 06; 2010. PMID: 20049168    Free PMC article.
Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20.
Eleftherios P Mamounas, Gong Tang, +7 authors, Norman Wolmark.
J Clin Oncol, 2010 Jan 13; 28(10). PMID: 20065188    Free PMC article.
Highly Cited.
Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening.
E Ruiz-Garcia, V Scott, +4 authors, F Andre.
Br J Cancer, 2010 Jan 14; 102(3). PMID: 20068563    Free PMC article.
Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells.
Lihua H Wang, Thomas D Pfister, +8 authors, Robert J Kinders.
Clin Cancer Res, 2010 Jan 28; 16(3). PMID: 20103672    Free PMC article.
Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.
Malini Harigopal, William E Barlow, +10 authors, Daniel F Hayes.
Am J Pathol, 2010 Feb 13; 176(4). PMID: 20150438    Free PMC article.
Biochanin A Modulates Cell Viability, Invasion, and Growth Promoting Signaling Pathways in HER-2-Positive Breast Cancer Cells.
Vikas Sehdev, James C K Lai, Alok Bhushan.
J Oncol, 2010 Feb 20; 2009. PMID: 20169097    Free PMC article.
Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2-neu-positive breast cancer? A current debate.
Fausto Petrelli, Sandro Barni.
Med Oncol, 2010 Mar 03; 28(2). PMID: 20195801
Review.
Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244).
Jonathan R Dry, Sandra Pavey, +26 authors, Paul D Smith.
Cancer Res, 2010 Mar 11; 70(6). PMID: 20215513    Free PMC article.
Highly Cited.
18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.
Joseph R Osborne, Elisa Port, +5 authors, Steven Larson.
J Nucl Med, 2010 Mar 20; 51(4). PMID: 20237034    Free PMC article.
Clinical outcomes and correlates of TP53 mutations and cancer.
Ana I Robles, Curtis C Harris.
Cold Spring Harb Perspect Biol, 2010 Mar 20; 2(3). PMID: 20300207    Free PMC article.
Review.
Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value.
Rafael Molina, Jose M Augé, +6 authors, Martin Velasco.
Tumour Biol, 2010 Apr 03; 31(3). PMID: 20361287
Debating clinical utility.
Wylie Burke, A-M Laberge, N Press.
Public Health Genomics, 2010 Apr 17; 13(4). PMID: 20395690    Free PMC article.
Review of the clinical studies using the 21-gene assay.
Catherine M Kelly, Ellen Warner, +2 authors, Kathleen I Pritchard.
Oncologist, 2010 Apr 28; 15(5). PMID: 20421266    Free PMC article.
Review.
What should physicians look for in evaluating prognostic gene-expression signatures?
Jyothi Subramanian, Richard Simon.
Nat Rev Clin Oncol, 2010 Apr 28; 7(6). PMID: 20421890
Review.
Systems approaches to polypharmacology and drug discovery.
Aislyn D W Boran, Ravi Iyengar.
Curr Opin Drug Discov Devel, 2010 May 06; 13(3). PMID: 20443163    Free PMC article.
Review.
Epithelial-to-mesenchymal transitions and circulating tumor cells.
Arnaud Bonnomet, Anne Brysse, +4 authors, Christine Gilles.
J Mammary Gland Biol Neoplasia, 2010 May 08; 15(2). PMID: 20449641
Review.
At last, a predictive and prognostic marker for radiotherapy?
Philip Coates, John Dewar, Alastair M Thompson.
Breast Cancer Res, 2010 May 26; 12(3). PMID: 20497617    Free PMC article.
Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.
Tony Blick, Honor Hugo, +7 authors, Erik W Thompson.
J Mammary Gland Biol Neoplasia, 2010 Jun 04; 15(2). PMID: 20521089
Highly Cited. Review.
Molecular circuits of solid tumors: prognostic and predictive tools for bedside use.
Charles Ferté, Fabrice André, Jean-Charles Soria.
Nat Rev Clin Oncol, 2010 Jun 17; 7(7). PMID: 20551944
Review.
Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease.
Helen M Heneghan, Nicola Miller, +2 authors, Michael J Kerin.
Oncologist, 2010 Jun 26; 15(7). PMID: 20576643    Free PMC article.
Highly Cited.
Image analysis as an adjunct to manual HER-2 immunohistochemical review: a diagnostic tool to standardize interpretation.
Lynne Dobson, Catherine Conway, +8 authors, Elaine Kay.
Histopathology, 2010 Jun 30; 57(1). PMID: 20584089    Free PMC article.
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.
Harold J Burstein, Ann Alexis Prestrud, +16 authors, American Society of Clinical Oncology.
J Clin Oncol, 2010 Jul 14; 28(23). PMID: 20625130    Free PMC article.
Highly Cited. Systematic Review.
Knockdown of eIF4E suppresses cell growth and migration, enhances chemosensitivity and correlates with increase in Bax/Bcl-2 ratio in triple-negative breast cancer cells.
Fei-fei Zhou, Min Yan, +7 authors, Liang-ping Xia.
Med Oncol, 2010 Jul 24; 28(4). PMID: 20652449
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received.
S-J Dawson, N Makretsov, +17 authors, P Pharoah.
Br J Cancer, 2010 Jul 29; 103(5). PMID: 20664598    Free PMC article.
Highly Cited.
Tumor markers in clinical practice: General principles and guidelines.
S Sharma.
Indian J Med Paediatr Oncol, 2009 Jan 01; 30(1). PMID: 20668599    Free PMC article.
Systems pharmacology.
Aislyn D W Boran, Ravi Iyengar.
Mt Sinai J Med, 2010 Aug 06; 77(4). PMID: 20687178    Free PMC article.
Overexpression of POLQ confers a poor prognosis in early breast cancer patients.
Geoff S Higgins, Adrian L Harris, +3 authors, Francesca M Buffa.
Oncotarget, 2010 Aug 12; 1(3). PMID: 20700469    Free PMC article.
Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.
Rowan T Chlebowski, Garnet L Anderson, +13 authors, Marcia L Stefanick.
J Natl Cancer Inst, 2010 Aug 17; 102(18). PMID: 20709992    Free PMC article.
[HER2 ASCO guidelines. The answer to everything?].
E Burandt, G Sauter.
Pathologe, 2010 Aug 27; 31 Suppl 2. PMID: 20740285
Perspectives on Breast Cancer Management: Tailoring Treatment to the Individual Patient.
Christoph Thomssen.
Breast Care (Basel), 2008 Jan 01; 3(s1). PMID: 20824005    Free PMC article.
Prospective Biomarker Trials Chemo N0 and NNBC-3 Europe Validate the Clinical Utility of Invasion Markers uPA and PAI-1 in Node-Negative Breast Cancer.
Nadia Harbeck, Manfred Schmitt, +9 authors, Christoph Thomssen.
Breast Care (Basel), 2008 Jan 01; 3(s2). PMID: 20824008    Free PMC article.
Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.
Manfred Schmitt, Karin Mengele, +4 authors, Nadia Harbeck.
Breast Care (Basel), 2008 Jan 01; 3(s2). PMID: 20824007    Free PMC article.
Experience in Phase I Trials and an Upcoming Phase II Study with uPA Inhibitors in Metastatic Breast Cancer.
Lori J Goldstein.
Breast Care (Basel), 2008 Jan 01; 3(s2). PMID: 20824011    Free PMC article.
ER, PgR, HER-2, Ki-67, topoisomerase IIα, and nm23-H1 proteins expression as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer.
Xi-ru Li, Mei Liu, +5 authors, Xin Song.
Med Oncol, 2010 Sep 28; 28 Suppl 1. PMID: 20872186
Tumor gene expression profiling in women with breast cancer. Test category: prognostic.
Cecelia Bellcross, W David Dotson.
PLoS Curr, 2010 Sep 30; 2. PMID: 20877449    Free PMC article.
Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer.
Laura Evangelista, Zora Baretta, +5 authors, Guido Sotti.
Eur J Nucl Med Mol Imaging, 2010 Oct 01; 38(2). PMID: 20882280
Early detection of recurrent breast cancer using metabolite profiling.
Vincent M Asiago, Leiddy Z Alvarado, +4 authors, Daniel Raftery.
Cancer Res, 2010 Oct 21; 70(21). PMID: 20959483    Free PMC article.
Highly Cited.
Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding.
Daniel Miotto Dupont, Jeppe Buur Madsen, +4 authors, Peter André Andreasen.
RNA, 2010 Oct 22; 16(12). PMID: 20962041    Free PMC article.
Blood peptidome-degradome profile of breast cancer.
Yufeng Shen, Nikola Tolić, +8 authors, Richard D Smith.
PLoS One, 2010 Oct 27; 5(10). PMID: 20976186    Free PMC article.
Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer.
Karen S Anderson, Sahar Sibani, +14 authors, Joshua Labaer.
J Proteome Res, 2010 Oct 28; 10(1). PMID: 20977275    Free PMC article.
Breast cancer in the personal genomics era.
Rachel E Ellsworth, David J Decewicz, Craig D Shriver, Darrell L Ellsworth.
Curr Genomics, 2010 Nov 03; 11(3). PMID: 21037853    Free PMC article.
Adjuvant Systemic Therapy, Quo Vadis? Patient Selection, Prognostic and Predictive Factors.
Fatima Cardoso.
Breast Care (Basel), 2008 Jan 01; 3(6). PMID: 21048908    Free PMC article.
Histological, molecular and functional subtypes of breast cancers.
Gautam K Malhotra, Xiangshan Zhao, Hamid Band, Vimla Band.
Cancer Biol Ther, 2010 Nov 09; 10(10). PMID: 21057215    Free PMC article.
Review.
A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer.
Hua Zhao, Jie Shen, +3 authors, Song Liu.
PLoS One, 2010 Nov 10; 5(10). PMID: 21060830    Free PMC article.
Highly Cited.
Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels.
Vladimir Tolmachev, Helena Wållberg, +3 authors, Anna Orlova.
Eur J Nucl Med Mol Imaging, 2010 Nov 12; 38(3). PMID: 21069318
Node-Negative Breast Cancer: Which Patients Should Be Treated?
Marcus Schmidt.
Breast Care (Basel), 2008 Jan 01; 3(4). PMID: 21076603    Free PMC article.
Predicting prognosis of breast cancer with gene signatures: are we lost in a sea of data?
Takayuki Iwamoto, Lajos Pusztai.
Genome Med, 2010 Nov 26; 2(11). PMID: 21092148    Free PMC article.
High-mannose glycans are elevated during breast cancer progression.
Maria Lorna A de Leoz, Lawrence J T Young, +6 authors, Carlito B Lebrilla.
Mol Cell Proteomics, 2010 Nov 26; 10(1). PMID: 21097542    Free PMC article.
Biomarkers of metastatic potential in cultured adenocarcinoma clones.
Mustafa Kh Dabbous, M Margaret Jefferson, Lena Haney, Edwin L Thomas.
Clin Exp Metastasis, 2010 Nov 26; 28(2). PMID: 21104427
Autoantibodies to tumor-associated antigens in breast carcinoma.
Ettie Piura, Benjamin Piura.
J Oncol, 2010 Nov 30; 2010. PMID: 21113302    Free PMC article.
BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.
Henne Holstege, Hugo M Horlings, +5 authors, Jos Jonkers.
BMC Cancer, 2010 Dec 02; 10. PMID: 21118481    Free PMC article.
The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer.
Norma E Ramirez, Zhonghua Zhang, +7 authors, Mary M Zutter.
J Clin Invest, 2010 Dec 08; 121(1). PMID: 21135504    Free PMC article.
Mathematical Oncology: How Are the Mathematical and Physical Sciences Contributing to the War on Breast Cancer?
Arnaud H Chauviere, Haralampos Hatzikirou, +3 authors, Vittorio Cristini.
Curr Breast Cancer Rep, 2010 Dec 15; 2(3). PMID: 21151486    Free PMC article.
Contribution of biomarkers to personalized medicine.
Daniel F Hayes.
Breast Cancer Res, 2011 Jan 05; 12 Suppl 4. PMID: 21172087    Free PMC article.
Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer Assay.
Kim M Clark-Langone, Chithra Sangli, Jayadevi Krishnakumar, Drew Watson.
BMC Cancer, 2010 Dec 24; 10. PMID: 21176237    Free PMC article.
Testing for HER2 in Breast Cancer: A Continuing Evolution.
Sejal Shah, Beiyun Chen.
Patholog Res Int, 2010 Dec 29; 2011. PMID: 21188214    Free PMC article.
Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay.
Julia R Trosman, Stephanie L Van Bebber, Kathryn A Phillips.
J Oncol Pract, 2011 Jan 05; 6(5). PMID: 21197187    Free PMC article.
Structural basis for recognition of urokinase-type plasminogen activator by plasminogen activator inhibitor-1.
Zhonghui Lin, Longguang Jiang, +7 authors, Mingdong Huang.
J Biol Chem, 2011 Jan 05; 286(9). PMID: 21199867    Free PMC article.
RB1CC1 together with RB1 and p53 predicts long-term survival in Japanese breast cancer patients.
Tokuhiro Chano, Kaichiro Ikebuchi, +14 authors, Hidetoshi Okabe.
PLoS One, 2011 Jan 05; 5(12). PMID: 21203526    Free PMC article.
Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.
Gong Tang, Steven Shak, +6 authors, Norman Wolmark.
Breast Cancer Res Treat, 2011 Jan 12; 127(1). PMID: 21221771    Free PMC article.
Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach.
Masami Kadowaki, Takafumi Sangai, +9 authors, Masaru Miyazaki.
J Cancer Res Clin Oncol, 2011 Jan 22; 137(7). PMID: 21253761
Liquid based material from fine needle aspirates from breast carcinomas offers the possibility of long-time storage without significant loss of immunoreactivity of estrogen and progesterone receptors.
Torill Sauer, Kristin Ebeltoft, Mette Kristin Pedersen, Rolf Kåresen.
Cytojournal, 2011 Feb 08; 7. PMID: 21298022    Free PMC article.
Charting a course for genomic medicine from base pairs to bedside.
Eric D Green, Mark S Guyer, National Human Genome Research Institute.
Nature, 2011 Feb 11; 470(7333). PMID: 21307933
Highly Cited.
The value of serum biomarkers (Bc1, Bc2, Bc3) in the diagnosis of early breast cancer.
Kemal Atahan, Hakan Küpeli, +6 authors, Ercüment Tarcan.
Int J Med Sci, 2011 Feb 18; 8(2). PMID: 21326957    Free PMC article.
Challenges to developing proteomic-based breast cancer diagnostics.
Richard R Drake, Lisa H Cazares, +3 authors, Christine Laronga.
OMICS, 2011 Feb 22; 15(5). PMID: 21332380    Free PMC article.
Review.
Gene signatures of breast cancer progression and metastasis.
David I Rodenhiser, Joseph D Andrews, Theodore A Vandenberg, Ann F Chambers.
Breast Cancer Res, 2011 Feb 25; 13(1). PMID: 21345283    Free PMC article.
Review.
Reactivation of Syk gene by AZA suppresses metastasis but not proliferation of breast cancer cells.
Tian-Song Xia, Jing-Ping Shi, +6 authors, Yong-Bin Ding.
Med Oncol, 2011 Feb 25; 29(2). PMID: 21347717
German Recommendations for Diagnosis and Treatment of Breast Cancer 2008. What is New from the Breast Commission of the German Gynaecological Oncology Working Group (AGO)?
Eva J Kantelhardt, Christoph Thomssen.
Breast Care (Basel), 2008 Jan 01; 3(2). PMID: 21373211    Free PMC article.
Predictive markers in primary breast cancer compared with lymph node and bloodspread metastases.
Mohammad F El-Sibai, Cynthia Cohen, +2 authors, Momin T Siddiqui.
Int J Physiol Pathophysiol Pharmacol, 2009 Jan 01; 1(1). PMID: 21383878    Free PMC article.
Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma.
Ettie Piura, Benjamin Piura.
J Oncol, 2011 Mar 23; 2011. PMID: 21423545    Free PMC article.
Measurement of human epidermal growth factor receptor type-2 extracellular domain and cancer antigen 15-3 levels in needle washout fluid: a potential adjunct to the cytological diagnosis of breast cancer.
Shu Ichihara, Suzuko Moritani, +7 authors, Akiko Saito.
Virchows Arch, 2011 Mar 26; 458(5). PMID: 21437720
Clinicopathological features of triple-negative breast cancer in Taiwanese women.
Kuo Yao-Lung, Chen Dar-Ren, Chang Tsai-Wang.
Int J Clin Oncol, 2011 Apr 02; 16(5). PMID: 21455625
Design and multiseries validation of a web-based gene expression assay for predicting breast cancer recurrence and patient survival.
Ryan K Van Laar.
J Mol Diagn, 2011 Apr 05; 13(3). PMID: 21458382    Free PMC article.
Overexpressions of Cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications.
Seoung Wan Chae, Jin Hee Sohn, +6 authors, Jun Ho Kim.
Yonsei Med J, 2011 Apr 14; 52(3). PMID: 21488187    Free PMC article.
Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×Docetaxel.
Eva J Kantelhardt, Martina Vetter, +12 authors, Nadia Harbeck.
BMC Cancer, 2011 Apr 19; 11. PMID: 21496284    Free PMC article.
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.
George Somlo, Sean K Lau, +5 authors, Richard H Bruce.
Breast Cancer Res Treat, 2011 Apr 19; 128(1). PMID: 21499685    Free PMC article.
Biomarkers in cancer: is 'omices' the way to go.
Abdelbaset Buhmeida, Peer Zada Abdul Ali.
Libyan J Med, 2011 Apr 29; 6. PMID: 21526044    Free PMC article.
Clinical proteomics of breast cancer.
Y Baskın, T Yiğitbaşı.
Curr Genomics, 2011 May 03; 11(7). PMID: 21532837    Free PMC article.
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.
Amy R Peck, Agnieszka K Witkiewicz, +16 authors, Hallgeir Rui.
J Clin Oncol, 2011 May 18; 29(18). PMID: 21576635    Free PMC article.
Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased.
Rachel M Gonzalez, Don S Daly, +2 authors, Richard C Zangar.
Cancer Epidemiol Biomarkers Prev, 2011 May 19; 20(7). PMID: 21586622    Free PMC article.
Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
Zhian Liu, Alberto Fusi, +4 authors, Ulrich Keilholz.
J Transl Med, 2011 May 21; 9. PMID: 21595914    Free PMC article.
Dependence on endocytic receptor binding via a minimal binding motif underlies the differential prognostic profiles of SerpinE1 and SerpinB2 in cancer.
Blake J Cochran, David R Croucher, +2 authors, Marie Ranson.
J Biol Chem, 2011 May 25; 286(27). PMID: 21606492    Free PMC article.
Colorimetric immunoassay for detection of tumor markers.
Yongmei Yin, Ya Cao, Yuanyuan Xu, Genxi Li.
Int J Mol Sci, 2010 Jan 01; 11(12). PMID: 21614193    Free PMC article.
Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.
Ken Tawara, Julia T Oxford, Cheryl L Jorcyk.
Cancer Manag Res, 2011 Jun 01; 3. PMID: 21625400    Free PMC article.
Knowledge about genomic recurrence risk testing among breast cancer survivors.
Isaac M Lipkus, Susan T Vadaparampil, Paul B Jacobsen, Cheryl A Miree.
J Cancer Educ, 2011 Jun 21; 26(4). PMID: 21688183
p53 Expression in node-positive breast cancer patients: results from the Cancer and Leukemia Group B 9344 Trial (159905).
Jonathan F Lara, Ann D Thor, +15 authors, Cancer and Leukemia Group B.
Clin Cancer Res, 2011 Jun 23; 17(15). PMID: 21693655    Free PMC article.
TFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen Activator in breast cancer.
Keivan Majidzadeh-A, Rezvan Esmaeili, Nasrin Abdoli.
BMC Res Notes, 2011 Jun 28; 4. PMID: 21702980    Free PMC article.
Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells.
Allison W Welsh, Christopher B Moeder, +5 authors, David L Rimm.
J Clin Oncol, 2011 Jun 29; 29(22). PMID: 21709197    Free PMC article.
MUC1 and MUC4: switching the emphasis from large to small.
Huguette Albrecht, Kermit L Carraway.
Cancer Biother Radiopharm, 2011 Jul 07; 26(3). PMID: 21728842    Free PMC article.
Review.
Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer.
Ruth Oratz, Benjamin Kim, +4 authors, Michael Broder.
J Oncol Pract, 2011 Jul 07; 7(2). PMID: 21731516    Free PMC article.
Efficacy control of therapy using circulating epithelial tumor cells (CETC) as "liquid biopsy": trastuzumab in HER2/neu-positive breast carcinoma.
Katharina Pachmann, O Camara, +4 authors, I B Runnebaum.
J Cancer Res Clin Oncol, 2011 Jul 09; 137(9). PMID: 21739182    Free PMC article.
Prognostic and Predictive Markers for Treatment Decisions in Early Breast Cancer.
Elmar Stickeler.
Breast Care (Basel), 2011 Jul 23; 6(3). PMID: 21779224    Free PMC article.
Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.
Pierre-Emmanuel Colombo, Fernanda Milanezi, Britta Weigelt, Jorge S Reis-Filho.
Breast Cancer Res, 2011 Jul 27; 13(3). PMID: 21787441    Free PMC article.
Review.
The way forward in treating pancreatic cancer.
Valeriy Sedov, Elizabeth Poplin.
Ther Adv Med Oncol, 2010 May 01; 2(3). PMID: 21789131    Free PMC article.
Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence.
Mary Jo Fackler, Christopher B Umbricht, +13 authors, Saraswati Sukumar.
Cancer Res, 2011 Aug 10; 71(19). PMID: 21825015    Free PMC article.
Highly Cited.
A five-gene model predicts clinical outcome in ER+/PR+, early-stage breast cancers treated with adjuvant tamoxifen.
Daniel Alan Kerr, James L Wittliff.
Horm Cancer, 2011 Aug 10; 2(5). PMID: 21826535
Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers.
Kanwal P S Raghav, Leonel F Hernandez-Aya, +7 authors, Ana M Gonzalez-Angulo.
Cancer, 2011 Aug 13; 118(6). PMID: 21837669    Free PMC article.
Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?
Robin K Kelley, Alan P Venook.
Clin Colorectal Cancer, 2011 Aug 24; 10(2). PMID: 21859557    Free PMC article.
Review.
Do all patients with breast cancer require systemic adjuvant therapy?
Jennifer J Griggs, Daniel F Hayes.
J Natl Cancer Inst, 2011 Sep 02; 103(18). PMID: 21881041    Free PMC article.
The emerging importance of α-L-fucose in human breast cancer: a review.
Jay J Listinsky, Gene P Siegal, Catherine M Listinsky.
Am J Transl Res, 2011 Sep 10; 3(4). PMID: 21904652    Free PMC article.
Aberrant glycosylation associated with enzymes as cancer biomarkers.
Danni L Meany, Daniel W Chan.
Clin Proteomics, 2011 Sep 13; 8(1). PMID: 21906357    Free PMC article.
Clinical utility of serum tumor markers and circulating tumor cell assays in the treatment of breast cancer.
Vandana G Abramson, Ingrid A Mayer.
Curr Treat Options Oncol, 2011 Sep 16; 12(4). PMID: 21918859
Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.
Marieke A Vollebergh, Jos Jonkers, Sabine C Linn.
Cell Mol Life Sci, 2011 Sep 17; 69(2). PMID: 21922196
Review.
Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score.
Arif H Kamal, Charles L Loprinzi, +7 authors, Matthew P Goetz.
Oncologist, 2011 Sep 22; 16(10). PMID: 21934103    Free PMC article.
Pharmacoeconomic considerations in the treatment of breast cancer.
Athanasios Pallis, Vasiliki Tsiantou, Efi Simou, Nikos Maniadakis.
Clinicoecon Outcomes Res, 2010 Jan 01; 2. PMID: 21935314    Free PMC article.
Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges.
Laura E MacConaill, Paul Van Hummelen, Matthew Meyerson, William C Hahn.
Cancer Discov, 2011 Sep 22; 1(4). PMID: 21935500    Free PMC article.
Review.
Unravelling the complexity of metastasis - molecular understanding and targeted therapies.
Nilay Sethi, Yibin Kang.
Nat Rev Cancer, 2011 Sep 24; 11(10). PMID: 21941285
Highly Cited. Review.
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
Mitch Dowsett, Torsten O Nielsen, +19 authors, International Ki-67 in Breast Cancer Working Group.
J Natl Cancer Inst, 2011 Oct 01; 103(22). PMID: 21960707    Free PMC article.
Highly Cited.
Up-regulation of kin17 is essential for proliferation of breast cancer.
Tao Zeng, Hongyi Gao, +4 authors, Yan Zhang.
PLoS One, 2011 Oct 08; 6(9). PMID: 21980430    Free PMC article.
Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors.
Gong Tang, Jack Cuzick, +6 authors, Norman Wolmark.
J Clin Oncol, 2011 Oct 20; 29(33). PMID: 22010013    Free PMC article.
Condensed chromatin staining of CKAP2 as surrogate marker for mitotic figures.
Han-Seong Kim, Yong-Bock Choi, +9 authors, Kyeong-Man Hong.
J Cancer Res Clin Oncol, 2011 Oct 25; 138(1). PMID: 22020800
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review.
Elisabeth Luporsi, Fabrice André, +22 authors, Jean-Pierre Bellocq.
Breast Cancer Res Treat, 2011 Nov 04; 132(3). PMID: 22048814    Free PMC article.
Highly Cited. Review.
Minimal residual disease and circulating tumor cells in breast cancer.
Michail Ignatiadis, Monica Reinholz.
Breast Cancer Res, 2011 Nov 15; 13(5). PMID: 22078011    Free PMC article.
Review.
The breast cancer genome--a key for better oncology.
Hans Kristian Moen Vollan, Carlos Caldas.
BMC Cancer, 2011 Dec 02; 11. PMID: 22128823    Free PMC article.
Review.
Practical implications of gene-expression-based assays for breast oncologists.
Aleix Prat, Matthew J Ellis, Charles M Perou.
Nat Rev Clin Oncol, 2011 Dec 07; 9(1). PMID: 22143140    Free PMC article.
Highly Cited. Review.
How comparative effectiveness research can help advance 'personalized medicine' in cancer treatment.
Scott D Ramsey, David Veenstra, +3 authors, Laurence H Baker.
Health Aff (Millwood), 2011 Dec 08; 30(12). PMID: 22147853    Free PMC article.
Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients.
Sarika Jain, Maureen M Ward, +16 authors, Linda T Vahdat.
Breast Cancer Res Treat, 2011 Dec 14; 132(1). PMID: 22160642    Free PMC article.
Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site.
Rafael Molina, Xavier Bosch, +5 authors, Alfonso López-Soto.
Tumour Biol, 2011 Dec 14; 33(2). PMID: 22161237
AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.
Christoph Thomssen, Anton Scharl, Nadia Harbeck.
Breast Care (Basel), 2011 Dec 14; 6(4). PMID: 22164127    Free PMC article.
RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues.
Fay Wang, John Flanagan, +7 authors, Yuling Luo.
J Mol Diagn, 2011 Dec 15; 14(1). PMID: 22166544    Free PMC article.
Highly Cited.
Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study.
Nina Mortazavi-Jehanno, Anne-Laure Giraudet, +7 authors, Jean-Louis Alberini.
Eur J Nucl Med Mol Imaging, 2011 Dec 21; 39(3). PMID: 22183107
Can FDG PET/CT monitor the response to hormonal therapy in breast cancer patients?
Laura Evangelista, Domenico Rubello, Giorgio Saladini.
Eur J Nucl Med Mol Imaging, 2011 Dec 21; 39(3). PMID: 22183109
Luminal-B breast cancer and novel therapeutic targets.
Ben Tran, Philippe L Bedard.
Breast Cancer Res, 2012 Jan 06; 13(6). PMID: 22217398    Free PMC article.
Review.
Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430.
Anne F Schott, William E Barlow, +8 authors, Gabriel N Hortobagyi.
Oncologist, 2012 Jan 24; 17(2). PMID: 22267853    Free PMC article.
Gene expression profiling: changing face of breast cancer classification and management.
Robert Wesolowski, Bhuvaneswari Ramaswamy.
Gene Expr, 2012 Jan 25; 15(3). PMID: 22268293    Free PMC article.
Review.
Role of traditional and new biomarkers in breast carcinogenesis.
D Macis, M Cazzaniga, A De Censi, B Bonanni.
Ecancermedicalscience, 2009 Jan 01; 3. PMID: 22276018    Free PMC article.
Assessing treatment-selection markers using a potential outcomes framework.
Ying Huang, Peter B Gilbert, Holly Janes.
Biometrics, 2012 Feb 04; 68(3). PMID: 22299708    Free PMC article.
Circulating tumor cells: highlight on practical implications.
Paola Gazzaniga, Cristina Raimondi, +3 authors, Luigi Frati.
Mol Diagn Ther, 2012 Feb 07; 16(1). PMID: 22303967
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study.
François-Clément Bidard, David Hajage, +8 authors, Jean-Yves Pierga.
Breast Cancer Res, 2012 Feb 15; 14(1). PMID: 22330883    Free PMC article.
Relationships between serum HER2 ECD, TIMP-1 and clinical outcomes in Taiwanese breast cancer.
Hsiu-Pei Tsai, Shin-Cheh Chen, +4 authors, Ling-Ling Hsieh.
World J Surg Oncol, 2012 Feb 22; 10. PMID: 22339939    Free PMC article.
Cancer biomarkers.
N Lynn Henry, Daniel F Hayes.
Mol Oncol, 2012 Feb 24; 6(2). PMID: 22356776    Free PMC article.
Highly Cited. Review.
Use of neoadjuvant data to design adjuvant endocrine therapy trials for breast cancer.
Rodrigo Goncalves, Cynthia Ma, +2 authors, Matthew James Ellis.
Nat Rev Clin Oncol, 2012 Mar 01; 9(4). PMID: 22371132    Free PMC article.
Review.
Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study.
John E Levine, Brent R Logan, +6 authors, Sophie Paczesny.
Blood, 2012 Mar 03; 119(16). PMID: 22383800    Free PMC article.
Bridging the gap: moving predictive and prognostic assays from research to clinical use.
P Michael Williams, Tracy G Lively, J Milburn Jessup, Barbara A Conley.
Clin Cancer Res, 2012 Mar 17; 18(6). PMID: 22422405    Free PMC article.
Patients with positive axillary lymph nodes: how to use genomic assays.
Ruta Rao.
Curr Treat Options Oncol, 2012 Mar 20; 13(2). PMID: 22426945
Current approaches to the management of Her2-negative metastatic breast cancer.
Keerthi Gogineni, Angela DeMichele.
Breast Cancer Res, 2012 Mar 21; 14(2). PMID: 22429313    Free PMC article.
Review.
Progress in circulating tumor cell capture and analysis: implications for cancer management.
Marija Balic, Henry Lin, +2 authors, Richard J Cote.
Expert Rev Mol Diagn, 2012 Apr 04; 12(3). PMID: 22468820    Free PMC article.
Review.
Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies.
Patricia A Deverka, Sheri D Schully, +5 authors, Scott D Ramsey.
Genet Med, 2012 Apr 07; 14(7). PMID: 22481130    Free PMC article.
Finding a place for genomics in health disparities research.
S M Fullerton, S Knerr, W Burke.
Public Health Genomics, 2012 Apr 11; 15(3-4). PMID: 22488458    Free PMC article.
Membrane progesterone receptor alpha as a potential prognostic biomarker for breast cancer survival: a retrospective study.
Mingxuan Xie, Xiangzhu Zhu, +6 authors, Shaojin You.
PLoS One, 2012 Apr 13; 7(4). PMID: 22496908    Free PMC article.
Cancer prognostics by direct detection of p53-antibodies on gold surfaces by impedance measurements.
Elisabet Prats-Alfonso, Xavier Sisquella, +9 authors, Fernando Albericio.
Small, 2012 Apr 19; 8(13). PMID: 22511467    Free PMC article.
Pre-treatment hormonal receptor status and Ki67 index predict pathologic complete response to neoadjuvant trastuzumab/taxanes but not disease-free survival in HER2-positive breast cancer patients.
Guo-Chun Zhang, Xue-Ke Qian, +6 authors, Ning Liao.
Med Oncol, 2012 May 02; 29(5). PMID: 22547076
Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device.
Brian J Kirby, Mona Jodari, +12 authors, Paraskevi Giannakakou.
PLoS One, 2012 May 05; 7(4). PMID: 22558290    Free PMC article.
Highly Cited.
Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry.
Regine M Schoenherr, Jeffrey R Whiteaker, +7 authors, Amanda G Paulovich.
Proteomics, 2012 May 12; 12(8). PMID: 22577026    Free PMC article.
Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer.
Luigi Strizzi, Katharine M Hardy, +9 authors, Mary J C Hendrix.
Breast Cancer Res, 2012 May 15; 14(3). PMID: 22577960    Free PMC article.
Tumor markers in clinical practice: a review focusing on common solid cancers.
Michael J Duffy.
Med Princ Pract, 2012 May 16; 22(1). PMID: 22584792    Free PMC article.
Review.
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.
Michael J Hassett, Samuel M Silver, +12 authors, Jane C Weeks.
J Clin Oncol, 2012 May 16; 30(18). PMID: 22585699    Free PMC article.
Personal genomic testing as part of the complete breast cancer risk assessment: a case report.
Sara Riordan, David F Rodriguez, Shannon Kieran.
J Genet Couns, 2012 May 23; 21(5). PMID: 22610652
Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival.
Hyuna Sung, Sujee Jeon, +8 authors, Daehee Kang.
BMC Cancer, 2012 May 30; 12. PMID: 22639842    Free PMC article.
The association between the preoperative serum levels of lipocalin-2 and matrix metalloproteinase-9 (MMP-9) and prognosis of breast cancer.
Hyuna Sung, Ji-Yeob Choi, +10 authors, Daehee Kang.
BMC Cancer, 2012 May 30; 12. PMID: 22640376    Free PMC article.
Statistical challenges in the development and evaluation of marker-based clinical tests.
Lisa M McShane.
BMC Med, 2012 May 31; 10. PMID: 22642713    Free PMC article.
Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach.
Daniel Böhm, Ksenia Keller, +8 authors, Franz-Hermann Grus.
Oncol Rep, 2012 Jun 06; 28(2). PMID: 22664934    Free PMC article.
Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer.
N Androulakis, S Agelaki, +7 authors, V Georgoulias.
Br J Cancer, 2012 Jun 07; 106(12). PMID: 22669159    Free PMC article.
Predicting the response to preoperative radiation or chemoradiation by a microarray analysis of the gene expression profiles in rectal cancer.
Takashi Akiyoshi, Takashi Kobunai, Toshiaki Watanabe.
Surg Today, 2012 Jun 19; 42(8). PMID: 22706722
Review.
Stromal genes add prognostic information to proliferation and histoclinical markers: a basis for the next generation of breast cancer gene signatures.
Dwain Mefford, Joel Mefford.
PLoS One, 2012 Jun 22; 7(6). PMID: 22719844    Free PMC article.
Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?
Jeffrey G Schneider, Danny N Khalil.
Breast Cancer Res Treat, 2012 Jun 23; 134(3). PMID: 22723033    Free PMC article.
Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy.
Shigeto Ueda, Darren Roblyer, +9 authors, Bruce J Tromberg.
Cancer Res, 2012 Jul 11; 72(17). PMID: 22777823    Free PMC article.
Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
Parul Gupta, Sanjay K Srivastava.
BMC Med, 2012 Jul 25; 10. PMID: 22824293    Free PMC article.
Molecular markers in peripheral blood of Iranian women with breast cancer.
Mana Oloomi, Saeid Bouzari, Mohammad-Ali Mohagheghi, Hamideh Khodayaran-Tehrani.
Cancer Microenviron, 2012 Jul 26; 6(1). PMID: 22828927    Free PMC article.
Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer.
Nadia Howlader, Anne-Michelle Noone, Mandi Yu, Kathleen A Cronin.
Am J Epidemiol, 2012 Jul 31; 176(4). PMID: 22842721    Free PMC article.
Understanding how breast cancer patients use risk information from genomic tests.
Jessica T DeFrank, Lisa A Carey, Noel T Brewer.
J Behav Med, 2012 Aug 11; 36(6). PMID: 22878783    Free PMC article.
Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS.
Nadiyah Sulayman, Elizabeth Spellman, +4 authors, Suzanne C O'Neill.
J Cancer Epidemiol, 2012 Aug 18; 2012. PMID: 22899924    Free PMC article.
Treatment Choices Based on OncotypeDx in the Breast Oncology Care Setting.
Teri L Malo, Isaac Lipkus, +3 authors, Susan T Vadaparampil.
J Cancer Epidemiol, 2012 Aug 29; 2012. PMID: 22927848    Free PMC article.
Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid.
Stephen A Whelan, Jianbo He, +5 authors, Helena R Chang.
J Proteome Res, 2012 Sep 01; 11(10). PMID: 22934887    Free PMC article.
Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.
Mohamed Elfagieh, Fathi Abdalla, +3 authors, Abdelbaset Buhmeida.
Tumour Biol, 2012 Sep 06; 33(6). PMID: 22948780
Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.
Anna-Karin Falck, Pär-Ola Bendahl, +7 authors, Lisa Rydén.
BMC Cancer, 2012 Sep 12; 12. PMID: 22963449    Free PMC article.
Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer.
Malek B Hannouf, Bin Xie, Muriel Brackstone, Gregory S Zaric.
BMC Cancer, 2012 Oct 04; 12. PMID: 23031196    Free PMC article.
Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism.
Kenneth A Botkjaer, Elena I Deryugina, +8 authors, Peter A Andreasen.
Mol Cancer Res, 2012 Oct 06; 10(12). PMID: 23038812    Free PMC article.
Publication of tumor marker research results: the necessity for complete and transparent reporting.
Lisa M McShane, Daniel F Hayes.
J Clin Oncol, 2012 Oct 17; 30(34). PMID: 23071235    Free PMC article.
Review.
Methods in comparative effectiveness research.
Katrina Armstrong.
J Clin Oncol, 2012 Oct 17; 30(34). PMID: 23071240    Free PMC article.
Review.
Serum microRNA-155 as a potential biomarker to track disease in breast cancer.
Yu Sun, Minjie Wang, +4 authors, Jinming Li.
PLoS One, 2012 Oct 17; 7(10). PMID: 23071695    Free PMC article.
Highly Cited.
Plasma matrix metalloproteinases and postmenopausal breast cancer risk: a nested case-control study in the Multiethnic Cohort study.
Yeonju Kim, Nicholas J Ollberding, +8 authors, Marc T Goodman.
Breast Cancer Res Treat, 2012 Nov 01; 136(3). PMID: 23112106    Free PMC article.
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX.
Alan S Coates, Ewan K A Millar, +10 authors, Robert L Sutherland.
Breast Cancer Res, 2012 Nov 07; 14(6). PMID: 23127292    Free PMC article.
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use.
W Eiermann, M Rezai, +13 authors, J Blohmer.
Ann Oncol, 2012 Nov 09; 24(3). PMID: 23136233    Free PMC article.
Barriers to the use of personalized medicine in breast cancer.
Christine B Weldon, Julia R Trosman, +2 authors, Julian C Schink.
J Oncol Pract, 2012 Nov 28; 8(4). PMID: 23180995    Free PMC article.
Non-invasive proteomics-thinking about personalized breast cancer screening and treatment.
Manuel Debald, Matthias Wolfgarten, +2 authors, Michael Braun.
EPMA J, 2010 Sep 01; 1(3). PMID: 23199085    Free PMC article.
The front line of genomic translation.
Suzanne C O'Neill, Colleen M McBride, +2 authors, Louise Wideroff.
J Cancer Epidemiol, 2012 Dec 05; 2012. PMID: 23209467    Free PMC article.
Overexpression of the secretory small GTPase Rab27B in human breast cancer correlates closely with lymph node metastasis and predicts poor prognosis.
Jia-Xing Zhang, Xiao-Xia Huang, +10 authors, Shi-Juan Mai.
J Transl Med, 2012 Dec 12; 10. PMID: 23217148    Free PMC article.
Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer.
A M Gonzalez-Angulo, G R Blumenschein.
Cancer Treat Rev, 2012 Dec 12; 39(4). PMID: 23218708    Free PMC article.
Clinical implementation of RNA signatures for pharmacogenomic decision-making.
Weihua Tang, Zhiyuan Hu, Hind Muallem, Margaret L Gulley.
Pharmgenomics Pers Med, 2011 Jan 01; 4. PMID: 23226056    Free PMC article.
Relationship between circulating and tissue microRNAs in a murine model of breast cancer.
Peadar S Waters, Ailbhe M McDermott, +5 authors, Roisin M Dwyer.
PLoS One, 2012 Dec 12; 7(11). PMID: 23226290    Free PMC article.
Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis.
Nuran Bektas Serce, Andreas Boesl, +10 authors, Edgar Dahl.
BMC Cancer, 2012 Dec 15; 12. PMID: 23236990    Free PMC article.
Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer.
C Palmieri, M P Caley, +8 authors, J Sturge.
Br J Cancer, 2012 Dec 22; 108(1). PMID: 23257899    Free PMC article.
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement.
H A Azim, S Michiels, +9 authors, C Swanton.
Ann Oncol, 2013 Jan 23; 24(3). PMID: 23337633    Free PMC article.
HER2 Status by Standardized Immunohistochemistry and Silver-Enhanced In Situ Hybridization in Korean Breast Cancer.
Young Kyung Bae, Gyungyub Gong, +7 authors, Breast Pathology Study Group of Korean Society of Pathologists.
J Breast Cancer, 2013 Jan 25; 15(4). PMID: 23346165    Free PMC article.
An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer.
Julius W Kim, Joel N Glasgow, +3 authors, David T Curiel.
PLoS One, 2013 Feb 06; 8(2). PMID: 23383334    Free PMC article.
A new genome-driven integrated classification of breast cancer and its implications.
Sarah-Jane Dawson, Oscar M Rueda, Samuel Aparicio, Carlos Caldas.
EMBO J, 2013 Feb 12; 32(5). PMID: 23395906    Free PMC article.
Highly Cited. Review.
Immunohistochemical expression of COX2 and iNOS in bladder cancer and its association with urinary schistosomiasis among Sudanese patients.
Hassan Elsiddig Hassan, Ahmed Abdel Badie Mohamed, Amel Omer Bakhiet, Hussain Gadelkarim Ahmed.
Infect Agent Cancer, 2013 Feb 19; 8(1). PMID: 23414519    Free PMC article.
A novel cancer testis antigen, A-kinase anchor protein 4 (AKAP4) is a potential biomarker for breast cancer.
Shikha Saini, Nirmala Jagadish, +2 authors, Anil Suri.
PLoS One, 2013 Mar 02; 8(2). PMID: 23451156    Free PMC article.
Cytokeratin19-2g2, a novel fragment of cytokeratin19 in serum, indicating a more invasive behavior and worse prognosis in breast cancer patients.
Yanan Kong, Junye Wang, +12 authors, Shuqin Dai.
PLoS One, 2013 Mar 08; 8(2). PMID: 23468917    Free PMC article.
DNA Methylation Profiles of Protease Nexin 1 (SERPINE2) Gene in Human Cell Lines.
Shan Gao, Peter A Andreasen.
Chin J Cancer Res, 2011 Jun 01; 23(2). PMID: 23482841    Free PMC article.
Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer.
Jeffrey B Smerage, G Thomas Budd, +9 authors, Daniel F Hayes.
Mol Oncol, 2013 Mar 30; 7(3). PMID: 23538216    Free PMC article.
Cathepsin D: Autoantibody profiling as a diagnostic marker for cancers.
Vaclav Vetvicka, Martin Fusek.
World J Clin Oncol, 2013 Mar 30; 4(1). PMID: 23538881    Free PMC article.
Organ Specific Tumor Markers: What's New?
Kannan Vaidyanathan, D M Vasudevan.
Indian J Clin Biochem, 2013 Apr 02; 27(2). PMID: 23542399    Free PMC article.
Inverse correlation between Naa10p and MMP-9 expression and the combined prognostic value in breast cancer patients.
Yan Zeng, Caiyun Liu, +7 authors, Chengchao Shou.
Med Oncol, 2013 Apr 04; 30(2). PMID: 23550278
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
Carina Strand, Martin Bak, +13 authors, Mårten Fernö.
Springerplus, 2013 Apr 06; 2(1). PMID: 23560250    Free PMC article.
Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer.
Xuejun Dong, Mingfeng Yang, +4 authors, Li Zhong.
Onco Targets Ther, 2013 Apr 10; 6. PMID: 23569391    Free PMC article.
Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer.
Emma Yue Zhang, Massimo Cristofanilli, +14 authors, William S Hancock.
J Proteome Res, 2013 May 08; 12(6). PMID: 23647160    Free PMC article.
Identification and validation of a new set of five genes for prediction of risk in early breast cancer.
Giorgio Mustacchi, Maria Pia Sormani, +5 authors, Luca Morandi.
Int J Mol Sci, 2013 May 08; 14(5). PMID: 23648477    Free PMC article.
The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer.
Nadiyah Kazmi, Diana C Márquez-Garbán, +4 authors, Richard J Pietras.
Lung Cancer Manag, 2013 May 08; 1(4). PMID: 23650476    Free PMC article.
Blocking the attachment of cancer cells in vivo with DNA aptamers displaying anti-adhesive properties against the carcinoembryonic antigen.
Erik W Orava, Aws Abdul-Wahid, +2 authors, Jean Gariépy.
Mol Oncol, 2013 May 10; 7(4). PMID: 23656757    Free PMC article.
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry.
E C Inwald, M Klinkhammer-Schalke, +4 authors, O Ortmann.
Breast Cancer Res Treat, 2013 May 16; 139(2). PMID: 23674192    Free PMC article.
Highly Cited.
A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the U.K.
S Holt, G Bertelli, +12 authors, C J Phillips.
Br J Cancer, 2013 May 23; 108(11). PMID: 23695023    Free PMC article.
Circulating tumour cells and cell-free DNA as tools for managing breast cancer.
Leticia De Mattos-Arruda, Javier Cortes, +4 authors, Joan Seoane.
Nat Rev Clin Oncol, 2013 May 29; 10(7). PMID: 23712187
Review.
Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses.
Roman Rouzier, Paolo Pronzato, +3 authors, William J Valentine.
Breast Cancer Res Treat, 2013 Jun 01; 139(3). PMID: 23722312    Free PMC article.
Systematic Review.
Predicting drug responsiveness in human cancers using genetically engineered mice.
Jerry Usary, Wei Zhao, +14 authors, Charles M Perou.
Clin Cancer Res, 2013 Jun 20; 19(17). PMID: 23780888    Free PMC article.
Detecting circulating tumor cells: current challenges and new trends.
Bin Hong, Youli Zu.
Theranostics, 2013 Jun 20; 3(6). PMID: 23781285    Free PMC article.
Highly Cited. Review.
The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients.
Salomon M Stemmer, Shmuel H Klang, +7 authors, Nicky Lieberman.
Breast Cancer Res Treat, 2013 Jun 27; 140(1). PMID: 23801158    Free PMC article.
Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures.
Dharanija Madhavan, Katarina Cuk, Barbara Burwinkel, Rongxi Yang.
Front Genet, 2013 Jun 27; 4. PMID: 23802013    Free PMC article.
Regulation of BMI1 Polycomb gene expression in histological grades of invasive ductal breast carcinomas and its correlation with hormone receptor status.
M V S Parvathi, P Balakrishna Murthy, M Vennila, B V Suresh.
Tumour Biol, 2013 Jul 23; 34(6). PMID: 23873108
The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis.
P Yang, C W Du, +2 authors, G J Zhang.
Sci Rep, 2013 Jul 23; 3. PMID: 23873310    Free PMC article.
Breast cancer metastasis: issues for the personalization of its prevention and treatment.
Natascia Marino, Stephan Woditschka, +4 authors, Patricia S Steeg.
Am J Pathol, 2013 Jul 31; 183(4). PMID: 23895915    Free PMC article.
Review.
Evaluating use characteristics for the oncotype dx 21-gene recurrence score and concordance with chemotherapy use in early-stage breast cancer.
Clara Chen, Rahul Dhanda, +2 authors, Debra A Patt.
J Oncol Pract, 2013 Aug 15; 9(4). PMID: 23942918    Free PMC article.
Analysis of circulating tumor cells in breast cancer.
Zeynep Eroglu, Odicie Fielder, George Somlo.
J Natl Compr Canc Netw, 2013 Aug 16; 11(8). PMID: 23946176    Free PMC article.
Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer.
Xiaosong Chen, Long Sun, +10 authors, Kunwei Shen.
BMC Cancer, 2013 Aug 21; 13. PMID: 23957561    Free PMC article.
Binding and isolation of tumor cells in biological media with perfluorocarbon microbubbles.
Guixin Shi, Wenjin Cui, +2 authors, Dmitri Simberg.
Methods, 2013 Aug 27; 64(2). PMID: 23974072    Free PMC article.
The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis.
Josh J Carlson, Joshua A Roth.
Breast Cancer Res Treat, 2013 Aug 27; 141(1). PMID: 23974828    Free PMC article.
Highly Cited. Systematic Review.
Identification of novel autoantibodies for detection of malignant mesothelioma.
Xufei Zhang, Weike Shen, +5 authors, Li Zhong.
PLoS One, 2013 Aug 27; 8(8). PMID: 23977302    Free PMC article.
Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancer.
Otto Metzger-Filho, Aurélie Catteau, +21 authors, Christos Sotiriou.
PLoS One, 2013 Aug 31; 8(8). PMID: 23990869    Free PMC article.
Evaluating the 21-gene assay Recurrence Score® as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer.
Takayuki Ueno, Norikazu Masuda, +12 authors, Masakazu Toi.
Int J Clin Oncol, 2013 Oct 09; 19(4). PMID: 24101215
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies.
Dejan Knezevic, Audrey D Goddard, +8 authors, Christopher Quale.
BMC Genomics, 2013 Oct 10; 14. PMID: 24103217    Free PMC article.
Highly Cited.
Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications.
Ramdane Harouaka, Zhigang Kang, Si-Yang Zheng, Liang Cao.
Pharmacol Ther, 2013 Oct 19; 141(2). PMID: 24134902    Free PMC article.
Review.
Circulating proteolytic products of carboxypeptidase N for early detection of breast cancer.
Yaojun Li, Yueguo Li, +6 authors, Ye Hu.
Clin Chem, 2013 Oct 23; 60(1). PMID: 24146311    Free PMC article.
Clinical and Biological Significance of Cathepsin D Levels in Breast Cancer Cytosol in Women Over 70 years.
Alvaro Ruibal, Michel Herranz, José Ignacio Arias.
Biomark Cancer, 2012 Jan 01; 4. PMID: 24179390    Free PMC article.
Plasma microRNA panel for minimally invasive detection of breast cancer.
Katarina Cuk, Manuela Zucknick, +10 authors, Barbara Burwinkel.
PLoS One, 2013 Nov 07; 8(10). PMID: 24194846    Free PMC article.
The human cell surfaceome of breast tumors.
Júlia Pinheiro Chagas da Cunha, Pedro Alexandre Favoretto Galante, +5 authors, Sandro José de Souza.
Biomed Res Int, 2013 Nov 07; 2013. PMID: 24195083    Free PMC article.
An international Ki67 reproducibility study.
Mei-Yin C Polley, Samuel C Y Leung, +16 authors, International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group.
J Natl Cancer Inst, 2013 Nov 10; 105(24). PMID: 24203987    Free PMC article.
Highly Cited.
OMICS-based personalized oncology: if it is worth doing, it is worth doing well!
Daniel F Hayes.
BMC Med, 2013 Nov 16; 11. PMID: 24228698    Free PMC article.
Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis.
Rahber Thariani, Norah Lynn Henry, +4 authors, David L Veenstra.
J Comp Eff Res, 2013 Nov 19; 2(3). PMID: 24236631    Free PMC article.
MicroRNA-21 in breast cancer: diagnostic and prognostic potential.
J Chen, X Wang.
Clin Transl Oncol, 2013 Nov 20; 16(3). PMID: 24248894
Review.
Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines.
Abigail Silva, Garth H Rauscher, +2 authors, Carol Estwing Ferrans.
Breast Cancer Res Treat, 2013 Nov 23; 142(3). PMID: 24265033    Free PMC article.
Cancer biomarkers: are we ready for the prime time?
Alok Mishra, Mukesh Verma.
Cancers (Basel), 2010 Jan 01; 2(1). PMID: 24281040    Free PMC article.
Significance of micrometastases: circulating tumor cells and disseminated tumor cells in early breast cancer.
Catherine Oakman, Marta Pestrin, +2 authors, Angelo Di Leo.
Cancers (Basel), 2010 Jan 01; 2(2). PMID: 24281114    Free PMC article.
MicroRNAs and triple negative breast cancer.
Elvira D'Ippolito, Marilena V Iorio.
Int J Mol Sci, 2013 Nov 29; 14(11). PMID: 24284394    Free PMC article.
Review.
Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies.
Manfred Schmitt, Viktor Magdolen, +6 authors, Julia Dorn.
Radiol Oncol, 2013 Dec 03; 47(4). PMID: 24294176    Free PMC article.
Review.
The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.
Marie Klintman, Carina Strand, +11 authors, Mårten Fernö.
PLoS One, 2013 Dec 11; 8(12). PMID: 24324728    Free PMC article.
How do I follow patients with early breast cancer after completing adjuvant therapy.
Jennifer M Matro, Lori J Goldstein.
Curr Treat Options Oncol, 2013 Dec 19; 15(1). PMID: 24346688
Review.
Optimal management of bone metastases in breast cancer patients.
Mh Wong, N Pavlakis.
Breast Cancer (Dove Med Press), 2011 Jan 01; 3. PMID: 24367175    Free PMC article.
Review.
DACH1: its role as a classifier of long term good prognosis in luminal breast cancer.
Desmond G Powe, Gopal Krishna R Dhondalay, +5 authors, Graham R Ball.
PLoS One, 2014 Jan 07; 9(1). PMID: 24392136    Free PMC article.
Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.
Byung-Joon Park, Mee-Kyung Cha, Il-Han Kim.
BMC Res Notes, 2014 Jan 08; 7. PMID: 24393391    Free PMC article.
Current approaches and challenges in monitoring treatment responses in breast cancer.
Lindsey J Graham, Matthew P Shupe, +9 authors, Nathan M Shumway.
J Cancer, 2014 Jan 08; 5(1). PMID: 24396498    Free PMC article.
Review.
Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.
Xinxin Liu, Yurong Chai, +6 authors, Jian-Ying Zhang.
Tumour Biol, 2014 Jan 09; 35(3). PMID: 24399648    Free PMC article.
Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.
Ning Qing Liu, Christoph Stingl, +15 authors, Arzu Umar.
J Natl Cancer Inst, 2014 Jan 09; 106(2). PMID: 24399849    Free PMC article.
MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.
Qifeng Luo, Chuankui Wei, +6 authors, Lin Fang.
Oncol Rep, 2014 Jan 10; 31(3). PMID: 24402230    Free PMC article.
Is symptom-oriented follow-up still up to date?
Christoph Mundhenke, Volker Moebus.
Breast Care (Basel), 2014 Jan 15; 8(5). PMID: 24415986    Free PMC article.
Review.
Breast Cancer Biomarkers: Utility in Clinical Practice.
Fanny Le Du, Naoto T Ueno, Ana M Gonzalez-Angulo.
Curr Breast Cancer Rep, 2014 Jan 15; 5(4). PMID: 24416469    Free PMC article.
The application of Oncotype DX in early-stage lymph-node-positive disease.
Sarika Jain, William J Gradishar.
Curr Oncol Rep, 2014 Jan 21; 16(1). PMID: 24442572
Review.
Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response.
Ho-Chang Lee, Hyoungsuk Ko, +5 authors, In Ae Park.
J Breast Cancer, 2014 Jan 24; 16(4). PMID: 24454461    Free PMC article.
Utilization of Oncotype DX in an Inner City Population: Race or Place?
Amber A Guth, Susan Fineberg, +2 authors, Nina A Bickell.
Int J Breast Cancer, 2014 Jan 24; 2013. PMID: 24455283    Free PMC article.
An ultra-sensitive immunoassay for quantifying biomarkers in breast tumor tissue.
Carol B Fowler, Yan-Gao Man, Jeffrey T Mason.
J Cancer, 2014 Feb 05; 5(2). PMID: 24494029    Free PMC article.
Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.
Carol Sweeney, Philip S Bernard, +11 authors, Bette J Caan.
Cancer Epidemiol Biomarkers Prev, 2014 Feb 14; 23(5). PMID: 24521995    Free PMC article.
Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer.
Antonino Grassadonia, Marta Di Nicola, +14 authors, Ettore Cianchetti.
Ann Surg Oncol, 2014 Feb 14; 21(5). PMID: 24522992    Free PMC article.
Nuclear factor-ĸB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells.
Kumiko Oida, Akira Matsuda, +9 authors, Akane Tanaka.
Sci Rep, 2014 Feb 18; 4. PMID: 24531845    Free PMC article.
Genomic profiling in luminal breast cancer.
Oleg Gluz, Daniel Hofmann, +3 authors, Nadia Harbeck.
Breast Care (Basel), 2014 Feb 20; 8(6). PMID: 24550749    Free PMC article.
Review.
Oncogenic processes.
Rita de Cassia Stocco, Franco Peppino Roperto, Lubna Nasir, Marcelo Palma Sircili.
Biomed Res Int, 2014 Feb 20; 2014. PMID: 24551854    Free PMC article.
Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.
Henrica M J Werner, Jone Trovik, +7 authors, Helga B Salvesen.
PLoS One, 2014 Mar 04; 9(2). PMID: 24587245    Free PMC article.
Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer.
Kristin Jonsdottir, Jörg Assmus, +4 authors, Emiel A M Janssen.
PLoS One, 2014 Mar 07; 9(3). PMID: 24599057    Free PMC article.
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens.
Torsten Nielsen, Brett Wallden, +7 authors, James Storhoff.
BMC Cancer, 2014 Mar 15; 14. PMID: 24625003    Free PMC article.
Highly Cited.
Impact of tumour epithelial subtype on circulating microRNAs in breast cancer patients.
Peadar S Waters, Roisin M Dwyer, +7 authors, Michael J Kerin.
PLoS One, 2014 Mar 15; 9(3). PMID: 24626163    Free PMC article.
Promoting quality and evidence-based care in early-stage breast cancer follow-up.
N Lynn Henry, Lynn N Henry, +4 authors, Julie R Gralow.
J Natl Cancer Inst, 2014 Mar 15; 106(4). PMID: 24627271    Free PMC article.
Review.
Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer.
Georgios Lazaridis, Sofia Lambaki, +7 authors, George Fountzilas.
Strahlenther Onkol, 2014 Mar 25; 190(7). PMID: 24658605
Aberrant glycosylation as biomarker for cancer: focus on CD43.
Franca Maria Tuccillo, Annamaria de Laurentiis, +8 authors, Giuseppe Scala.
Biomed Res Int, 2014 Apr 02; 2014. PMID: 24689054    Free PMC article.
Review.
Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.
Philipp Mertins, Feng Yang, +28 authors, Steven A Carr.
Mol Cell Proteomics, 2014 Apr 11; 13(7). PMID: 24719451    Free PMC article.
Highly Cited.
Inhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression.
Parul Gupta, Sanjay K Srivastava.
Oncotarget, 2014 Apr 15; 5(7). PMID: 24729020    Free PMC article.
Serial Serum HER2 Measurements for the Detection of Breast Cancer Recurrence in HER2-Positive Patients.
June-Hyung Ha, Min-Ki Seong, +9 authors, Hyun-Ah Kim.
J Breast Cancer, 2014 Apr 20; 17(1). PMID: 24744795    Free PMC article.
Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients.
Kwan Il Kim, Kyung Hee Lee, +3 authors, Heung Kyu Park.
J Breast Cancer, 2014 Apr 20; 17(1). PMID: 24744796    Free PMC article.
A cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in Turkey.
Ali Arican, Tulin Bozkurt, +17 authors, Bahadir Pekin.
Support Care Cancer, 2014 Apr 23; 22(10). PMID: 24752566    Free PMC article.
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer.
T M A Abdel-Fatah, S E B McArdle, +6 authors, S Y T Chan.
Br J Cancer, 2014 Apr 24; 110(10). PMID: 24755885    Free PMC article.
Patients' perceptions of gene expression profiling in breast cancer treatment decisions.
Y Bombard, L Rozmovits, +3 authors, D A Marshall.
Curr Oncol, 2014 Apr 26; 21(2). PMID: 24764705    Free PMC article.
Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.
R Kreienberg, U-S Albert, +3 authors, A Wöckel.
Geburtshilfe Frauenheilkd, 2014 Apr 29; 73(6). PMID: 24771925    Free PMC article.
Current approaches and challenges in early detection of breast cancer recurrence.
Erika J Schneble, Lindsey J Graham, +10 authors, Robert F Setlik.
J Cancer, 2014 May 03; 5(4). PMID: 24790656    Free PMC article.
Review.
Circulating tumor cell data: integration with imaging and serum tumor markers for metastatic breast cancer patient management.
Thomas Marsland, Eric R Schuur.
Case Rep Oncol, 2014 May 08; 7(1). PMID: 24803895    Free PMC article.
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.
Harold J Burstein, Sarah Temin, +10 authors, Jennifer J Griggs.
J Clin Oncol, 2014 May 29; 32(21). PMID: 24868023    Free PMC article.
Highly Cited.
TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.
Charlotte Levin Tykjær Jørgensen, Christina Bjerre, +5 authors, Dorte L Nielsen.
BMC Cancer, 2014 Jun 03; 14. PMID: 24884504    Free PMC article.
Chromatin CKAP2, a new proliferation marker, as independent prognostic indicator in breast cancer.
Han-Seong Kim, Jae-Soo Koh, +12 authors, Kyeong-Man Hong.
PLoS One, 2014 Jun 03; 9(6). PMID: 24887265    Free PMC article.
Determination of the HER2 amplification status by in situ fluorescent hybridization and concordance with immunohistochemistry for breast cancer samples in Colombia.
Adriana Plata, Maria Mercedes Torres, Rocío López, Rafael E Andrade.
Colomb Med (Cali), 2013 Apr 01; 44(2). PMID: 24892456    Free PMC article.
Modern Risk Assessment for Individualizing Treatment Concepts in Early-stage Breast Cancer.
Alex Farr, Rachel Wuerstlein, +2 authors, Nadia Harbeck.
Rev Obstet Gynecol, 2013 Jan 01; 6(3-4). PMID: 24920978    Free PMC article.
A novel model for Ki67 assessment in breast cancer.
Quinci Romero, Pär-Ola Bendahl, +2 authors, Signe Borgquist.
Diagn Pathol, 2014 Jun 18; 9. PMID: 24934660    Free PMC article.
Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
Liping Chung, Katrina Moore, +3 authors, Robert C Baxter.
Breast Cancer Res, 2014 Jun 18; 16(3). PMID: 24935269    Free PMC article.
Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatment.
Y Bombard, L Rozmovits, +3 authors, D A Marshall.
Curr Oncol, 2014 Jun 19; 21(3). PMID: 24940102    Free PMC article.
miR-205 and miR-200c: Predictive Micro RNAs for Lymph Node Metastasis in Triple Negative Breast Cancer.
Ufuk Berber, Ismail Yilmaz, +3 authors, Dilaver Demirel.
J Breast Cancer, 2014 Jul 12; 17(2). PMID: 25013435    Free PMC article.
Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer.
Yilin Li, Xiaotian Zhang, +8 authors, Lin Shen.
Oncotarget, 2014 Jul 16; 5(16). PMID: 25026283    Free PMC article.
Type II transmembrane serine protease gene variants associate with breast cancer.
Kaisa Luostari, Jaana M Hartikainen, +4 authors, Veli-Matti Kosma.
PLoS One, 2014 Jul 17; 9(7). PMID: 25029565    Free PMC article.
Understanding the implications of the breast cancer pathology report: a case study.
Susan Beikman, Patricia Gordon, +3 authors, Margaret Q Rosenzweig.
J Adv Pract Oncol, 2013 May 01; 4(3). PMID: 25031998    Free PMC article.
Review.
Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use.
Laura Zanotti, Alberto Bottini, +2 authors, Maria Rosa Cappelletti.
Tumour Biol, 2014 Jul 23; 35(9). PMID: 25048969
Review.
Computational prognostic indicators for breast cancer.
Xinan Yang, Xindi Ai, John M Cunningham.
Cancer Manag Res, 2014 Jul 23; 6. PMID: 25050076    Free PMC article.
Review.
Current status of molecular biomarkers in endometrial cancer.
H M J Werner, H B Salvesen.
Curr Oncol Rep, 2014 Jul 30; 16(9). PMID: 25064587
Review.
Circulating levels and clinical implications of epithelial membrane antigen and cytokeratin-1 in women with breast cancer: can their ratio improve the results?
Abdelfattah M Attallah, Mohamed El-Far, +10 authors, Ahmed M El-Waseef.
Tumour Biol, 2014 Jul 31; 35(11). PMID: 25073515
Calponin-h2: a potential serum marker for the early detection of human breast cancer?
Manuel Debald, Jian-Ping Jin, +7 authors, Gisela Walgenbach-Brünagel.
Tumour Biol, 2014 Aug 08; 35(11). PMID: 25099617
Significance of immunohistochemistry in breast cancer.
Dana Carmen Zaha.
World J Clin Oncol, 2014 Aug 13; 5(3). PMID: 25114853    Free PMC article.
Review.
Biological subtypes of breast cancer: Prognostic and therapeutic implications.
Ozlem Yersal, Sabri Barutca.
World J Clin Oncol, 2014 Aug 13; 5(3). PMID: 25114856    Free PMC article.
Highly Cited. Review.
Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.
Andrew C Gordon, William J Gradishar, +6 authors, Robert J Lewandowski.
J Vasc Interv Radiol, 2014 Aug 27; 25(10). PMID: 25156827    Free PMC article.
Progesterone receptor status and Ki-67 index may predict early relapse in luminal B/HER2 negative breast cancer patients: a retrospective study.
Yu Zong, Li Zhu, +7 authors, Kunwei Shen.
PLoS One, 2014 Aug 30; 9(8). PMID: 25170613    Free PMC article.
Chemotherapy in early breast cancer: when, how and which one?
Marcus Schmidt.
Breast Care (Basel), 2014 Sep 02; 9(3). PMID: 25177256    Free PMC article.
Review.
Genome-based risk prediction for early stage breast cancer.
Christina Adaniel, Komal Jhaveri, Adriana Heguy, Francisco J Esteva.
Oncologist, 2014 Sep 05; 19(10). PMID: 25187476    Free PMC article.
Review.
Improved pharmacokinetic and biodistribution properties of the selective urokinase inhibitor PAI-2 (SerpinB2) by site-specific PEGylation: implications for drug delivery.
Kara Lea Vine, Sergei Lobov, +2 authors, Marie Ranson.
Pharm Res, 2014 Sep 19; 32(3). PMID: 25231010
The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre.
Terri Patricia McVeigh, Lauren M Hughes, +4 authors, Michael J Kerin.
Eur J Cancer, 2014 Sep 23; 50(16). PMID: 25240289    Free PMC article.
Nanotechnology for the detection and kill of circulating tumor cells.
Yang Gao, Zhou Yuan.
Nanoscale Res Lett, 2014 Sep 27; 9(1). PMID: 25258614    Free PMC article.
Prognostic significance of Ki-67 index value at the primary breast tumor in recurrent breast cancer.
Reiki Nishimura, Tomofumi Osako, +5 authors, Nobuyuki Arima.
Mol Clin Oncol, 2014 Oct 04; 2(6). PMID: 25279198    Free PMC article.
Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study.
Zhaolei Cui, Donghong Lin, +2 authors, Dan Li.
Tumour Biol, 2014 Oct 10; 36(2). PMID: 25296735
Tumor marker usage and medical care costs among older early-stage breast cancer survivors.
Scott D Ramsey, N Lynn Henry, +6 authors, David L Veenstra.
J Clin Oncol, 2014 Oct 22; 33(2). PMID: 25332254    Free PMC article.
Circulating free DNA in the management of breast cancer.
Jacqueline A Shaw, Justin Stebbing.
Ann Transl Med, 2014 Oct 22; 2(1). PMID: 25332979    Free PMC article.
Effects of a high-fat diet on spontaneous metastasis of Lewis lung carcinoma in plasminogen activator inhibitor-1 deficient and wild-type mice.
Lin Yan, Lana C DeMars.
PLoS One, 2014 Oct 31; 9(10). PMID: 25356654    Free PMC article.
Effect of circulating tumor cells combined with negative enrichment and CD45-FISH identification in diagnosis, therapy monitoring and prognosis of primary lung cancer.
Yang-Yang Chen, Guo-Bin Xu.
Med Oncol, 2014 Nov 02; 31(12). PMID: 25361883
The clinical impact of 21-gene recurrence score on treatment decisions for patients with hormone receptor-positive early breast cancer in Korea.
Moo Hyun Lee, Wonshik Han, +7 authors, Eun Sook Lee.
Cancer Res Treat, 2014 Nov 11; 47(2). PMID: 25381828    Free PMC article.
Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients.
Patricia R Blank, Martin Filipits, +11 authors, Michael Gnant.
Pharmacoeconomics, 2014 Nov 19; 33(2). PMID: 25404424    Free PMC article.
Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology.
Debora Fumagalli, Alexis Blanchet-Cohen, +13 authors, Benjamin Haibe-Kains.
BMC Genomics, 2014 Nov 22; 15. PMID: 25412710    Free PMC article.
The Evolving Role of Circulating Tumor Cells in the Personalized Management of Breast Cancer: from Enumeration to Molecular Characterization.
Sasmit Sarangi, Kailash Mosulpuria, Michaela J Higgins, Aditya Bardia.
Curr Breast Cancer Rep, 2014 Nov 29; 6(3). PMID: 25431637    Free PMC article.
Post-operative nomogram for predicting freedom from recurrence after surgery in localised breast cancer receiving adjuvant hormone therapy.
Chafika Mazouni, Frédéric Fina, +3 authors, Pierre-Marie Martin.
J Cancer Res Clin Oncol, 2014 Dec 01; 141(6). PMID: 25433507
Association of CA 15-3 and CEA with clinicopathological parameters in patients with metastatic breast cancer.
Biao Geng, Man-Man Liang, Xiao-Bing Ye, Wen-Ying Zhao.
Mol Clin Oncol, 2014 Dec 04; 3(1). PMID: 25469301    Free PMC article.
Clinical utility of gene-expression profiling in women with early breast cancer: an overview of systematic reviews.
Michael Marrone, Alison Stewart, W David Dotson.
Genet Med, 2014 Dec 05; 17(7). PMID: 25474343    Free PMC article.
Review.
Ectokinases as novel cancer markers and drug targets in cancer therapy.
Garif Yalak, Viola Vogel.
Cancer Med, 2014 Dec 17; 4(3). PMID: 25504773    Free PMC article.
Review.
Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Hong-Tai Chang, Chin Hu, +2 authors, Ren-Shyan Liu.
PLoS One, 2014 Dec 18; 9(12). PMID: 25517451    Free PMC article.
Circulating Tumor Cells: Who is the Killer?
Patrizia Paterlini-Bréchot.
Cancer Microenviron, 2014 Dec 21; 7(3). PMID: 25527469    Free PMC article.
Patterns of 21-gene assay testing and chemotherapy use in black and white breast cancer patients.
Vanessa B Sheppard, Suzanne C O'Neill, +3 authors, Claudine Isaacs.
Clin Breast Cancer, 2015 Jan 04; 15(2). PMID: 25555816    Free PMC article.
The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer.
Nikhil G Thaker, Karen E Hoffman, +10 authors, Wendy A Woodward.
Springerplus, 2015 Feb 13; 4. PMID: 25674496    Free PMC article.
uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies.
Michael J Duffy, Patricia M McGowan, +2 authors, Manfred Schmitt.
Breast Cancer Res, 2015 Feb 14; 16(4). PMID: 25677449    Free PMC article.
Highly Cited. Review.
Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients.
Sandra Heskamp, Otto C Boerman, +7 authors, Hanneke W M van Laarhoven.
PLoS One, 2015 Feb 14; 10(2). PMID: 25680198    Free PMC article.
Expression of integrin-binding protein Nischarin in metastatic breast cancer.
Jie Chen, Wei-Liang Feng, +2 authors, Shang-Nao Xie.
Mol Med Rep, 2015 Feb 20; 12(1). PMID: 25695373    Free PMC article.
An international study to increase concordance in Ki67 scoring.
Mei-Yin C Polley, Samuel C Y Leung, +28 authors, Torsten O Nielsen.
Mod Pathol, 2015 Feb 24; 28(6). PMID: 25698062
Highly Cited.
Risk stratification of prostate cancer in the modern era.
Andrew S Behesnilian, Robert E Reiter.
Curr Opin Urol, 2015 Mar 03; 25(3). PMID: 25730325    Free PMC article.
Review.
The value of personalizing medicine: medical oncologists' views on gene expression profiling in breast cancer treatment.
Yvonne Bombard, Linda Rozmovits, +3 authors, Deborah A Marshall.
Oncologist, 2015 Mar 10; 20(4). PMID: 25746345    Free PMC article.
Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity.
Linda M McInnes, Natalie Jacobson, +3 authors, Christobel M Saunders.
Front Oncol, 2015 Mar 15; 5. PMID: 25767772    Free PMC article.
Review.
Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.
Qi Shen, Aysegul A Sahin, +4 authors, Nuhad K Ibrahim.
Oncologist, 2015 Mar 25; 20(5). PMID: 25802405    Free PMC article.
D-pinitol mitigates tumor growth by modulating interleukins and hormones and induces apoptosis in rat breast carcinogenesis through inhibition of NF-κB.
Thamaraiselvan Rengarajan, Natarajan Nandakumar, +3 authors, Ikuo Nishigaki.
J Physiol Biochem, 2015 Apr 02; 71(2). PMID: 25827943
Multigene prognostic tests in breast cancer: past, present, future.
Balázs Győrffy, Christos Hatzis, +3 authors, Lajos Pusztai.
Breast Cancer Res, 2015 Apr 08; 17. PMID: 25848861    Free PMC article.
Highly Cited. Review.
Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay.
Elizabeth J Sutton, Jung Hun Oh, +5 authors, Elizabeth A Morris.
J Magn Reson Imaging, 2015 Apr 09; 42(5). PMID: 25850931    Free PMC article.
Highly Cited.
Cell surface-based sensing with metallic nanoparticles.
Ziwen Jiang, Ngoc D B Le, Akash Gupta, Vincent M Rotello.
Chem Soc Rev, 2015 Apr 09; 44(13). PMID: 25853985    Free PMC article.
Review.
MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.
J Xue, Y Chi, +8 authors, J Wu.
Oncogene, 2015 Apr 14; 35(4). PMID: 25867061    Free PMC article.
AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
Stefan Garczyk, Saskia von Stillfried, +9 authors, Edgar Dahl.
PLoS One, 2015 Apr 16; 10(4). PMID: 25875093    Free PMC article.
Circulating miR-200c and miR-141 and outcomes in patients with breast cancer.
Silvia Antolín, Lourdes Calvo, +7 authors, Manuel Valladares-Ayerbes.
BMC Cancer, 2015 Apr 18; 15. PMID: 25885099    Free PMC article.
HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer.
Vineesh Indira Chandran, Serenella Eppenberger-Castori, +2 authors, Marie Ranson.
Oncoscience, 2015 Apr 22; 2(3). PMID: 25897424    Free PMC article.
Review.
Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer.
Pavel Bouchal, Monika Dvořáková, +11 authors, Rudolf Nenutil.
Mol Cell Proteomics, 2015 Apr 24; 14(7). PMID: 25903579    Free PMC article.
Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model.
Jiahua Jiang, Daisy Dandan Wang, +8 authors, Peter Ping Lin.
Oncotarget, 2015 Apr 25; 6(17). PMID: 25909226    Free PMC article.
Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker.
Sayyed Farshid Moussavi-Harami, Kari B Wisinski, David J Beebe.
J Patient Cent Res Rev, 2015 Apr 29; 1(2). PMID: 25914894    Free PMC article.
MicroRNA-155 hallmarks promising accuracy for the diagnosis of various carcinomas: results from a meta-analysis.
Chuancheng Wu, Qiuyan Liu, Baoying Liu.
Dis Markers, 2015 Apr 29; 2015. PMID: 25918453    Free PMC article.
Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: a Chinese population-based study.
Nan Xu, Fei Chen, +4 authors, Cheng Lu.
Tumour Biol, 2015 May 02; 36(10). PMID: 25929808
Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score.
Bradley M Turner, Kristin A Skinner, +6 authors, David G Hicks.
Mod Pathol, 2015 May 02; 28(7). PMID: 25932962
8p deletion is strongly linked to poor prognosis in breast cancer.
P Lebok, A Mittenzwei, +21 authors, E Burandt.
Cancer Biol Ther, 2015 May 12; 16(7). PMID: 25961141    Free PMC article.
Early detection of breast cancer using total biochemical analysis of peripheral blood components: a preliminary study.
Udi Zelig, Eyal Barlev, +8 authors, Osnat Madhala-Givon.
BMC Cancer, 2015 May 16; 15. PMID: 25975566    Free PMC article.
Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.
Sabine Heublein, Doris Mayr, +6 authors, Nina Ditsch.
J Exp Clin Cancer Res, 2015 May 20; 34. PMID: 25986064    Free PMC article.
Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines.
Maryam Beigom Mobasheri, Reza Shirkoohi, +4 authors, Mohammad Hossein Modarressi.
Tumour Biol, 2015 May 23; 36(10). PMID: 25994570
Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up.
Marko Buta, Radan Džodić, +4 authors, Dragica Nikolić-Vukosavljević.
Tumour Biol, 2015 May 23; 36(10). PMID: 25994573
From bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?
Victoria Shang Wu, Noriko Kanaya, +2 authors, Shiuan Chen.
J Steroid Biochem Mol Biol, 2015 May 23; 153. PMID: 25998416    Free PMC article.
Review.
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.
V Bossuyt, E Provenzano, +18 authors, Breast International Group-North American Breast Cancer Group (BIG-NABCG) collaboration.
Ann Oncol, 2015 May 29; 26(7). PMID: 26019189    Free PMC article.
Review.
Treatment differences between urban and rural women with hormone receptor-positive early-stage breast cancer based on 21-gene assay recurrence score result.
Molly Andreason, Chong Zhang, +7 authors, Amye J Tevaarwerk.
J Community Support Oncol, 2015 Jun 02; 13(5). PMID: 26029936    Free PMC article.
Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-Analysis.
Sheng-Ming Deng, Wei Zhang, +3 authors, Yi-Wei Wu.
PLoS One, 2015 Jun 04; 10(6). PMID: 26038827    Free PMC article.
Systematic Review.
Plasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional Implications.
Domenica Scumaci, Laura Tammè, +8 authors, Giovanni Cuda.
PLoS One, 2015 Jun 11; 10(6). PMID: 26061043    Free PMC article.
Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France.
Gregory Katz, Olivier Romano, +7 authors, Rémy Salmon.
PLoS One, 2015 Jun 19; 10(6). PMID: 26086912    Free PMC article.
Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy.
Michel van Kruchten, Andor W J M Glaudemans, +3 authors, Geke A P Hospers.
Eur J Nucl Med Mol Imaging, 2015 Jun 21; 42(11). PMID: 26091705    Free PMC article.
Sampling circulating tumor cells for clinical benefits: how frequent?
Sai Mun Leong, Karen M L Tan, +6 authors, Evelyn S C Koay.
J Hematol Oncol, 2015 Jun 26; 8. PMID: 26108208    Free PMC article.
Review.
Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study.
Joseph Gligorov, Xavier B Pivot, +11 authors, Francilian Breast Intergroup.
Oncologist, 2015 Jun 27; 20(8). PMID: 26112003    Free PMC article.
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.
Alessandra Mangolini, Manuela Ferracin, +12 authors, Massimo Negrini.
Biomark Res, 2015 Jun 30; 3. PMID: 26120471    Free PMC article.
Epidemiological and Clinicopathological Trends of Breast Cancer in Chinese Patients During 1993 to 2013: A Retrospective Study.
Wen Si, Ying Li, +6 authors, Junlan Yang.
Medicine (Baltimore), 2015 Jul 02; 94(26). PMID: 26131834    Free PMC article.
Patterns of Care for Localized Breast Cancer in Oklahoma, 2003-2006.
Janis E Campbell, Amanda E Janitz, +2 authors, Anne Pate.
Women Health, 2015 Jul 03; 55(8). PMID: 26133913    Free PMC article.
Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase family.
Masaaki Kawai, Akio Nakashima, Shinji Kamada, Ushio Kikkawa.
J Biomed Sci, 2015 Jul 05; 22. PMID: 26141684    Free PMC article.
Fascin expression predicts an aggressive clinical course in patients with advanced breast cancer.
Kyueng-Whan Min, Seoung Wan Chae, +10 authors, Chan Heun Park.
Oncol Lett, 2015 Jul 15; 10(1). PMID: 26170987    Free PMC article.
Association between the ornithine decarboxylase G316A polymorphism and breast cancer survival.
Linping Xu, Jianping Long, +3 authors, Yongjun Guo.
Oncol Lett, 2015 Jul 15; 10(1). PMID: 26171056    Free PMC article.
Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study.
Rumiko Tashima, Reiki Nishimura, +6 authors, Nobuyuki Arima.
PLoS One, 2015 Jul 16; 10(7). PMID: 26177501    Free PMC article.
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Catherine Van Poznak, Mark R Somerfield, +12 authors, Lyndsay N Harris.
J Clin Oncol, 2015 Jul 22; 33(24). PMID: 26195705    Free PMC article.
Highly Cited.
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group.
Elena Provenzano, Veerle Bossuyt, +17 authors, Residual Disease Characterization Working Group of the Breast International Group-North American Breast Cancer Group Collaboration.
Mod Pathol, 2015 Jul 25; 28(9). PMID: 26205180
Highly Cited.
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
Yingbo Shao, Xianfu Sun, +2 authors, Hui Liu.
PLoS One, 2015 Jul 25; 10(7). PMID: 26207909    Free PMC article.
Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples.
Mario Campone, Isabelle Valo, +7 authors, Catherine Guette.
Mol Cell Proteomics, 2015 Jul 26; 14(11). PMID: 26209610    Free PMC article.
Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing.
Megan C Roberts, Morris Weinberger, +5 authors, Stephanie B Wheeler.
Breast Cancer Res Treat, 2015 Jul 29; 153(1). PMID: 26216535    Free PMC article.
Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment.
J Ribeiro, B Sousa, F Cardoso.
EJC Suppl, 2013 Sep 01; 11(2). PMID: 26217109    Free PMC article.
Review.
Effect of 21-Gene RT-PCR Assay on Adjuvant Therapy and Outcomes in Patients With Stage I Breast Cancer.
Fanny Le Du, Ana M Gonzalez-Angulo, +3 authors, Naoto T Ueno.
Clin Breast Cancer, 2015 Aug 04; 15(6). PMID: 26233757    Free PMC article.
Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells.
Feng Ge, Haishi Zhang, +2 authors, Peter Ping Lin.
Oncotarget, 2015 Aug 13; 6(29). PMID: 26267323    Free PMC article.
Progress in adjuvant chemotherapy for breast cancer: an overview.
Jesus Anampa, Della Makower, Joseph A Sparano.
BMC Med, 2015 Aug 19; 13. PMID: 26278220    Free PMC article.
Highly Cited. Review.
Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years.
Arnold L Potosky, Suzanne C O'Neill, +8 authors, Marc D Schwartz.
Cancer, 2015 Aug 21; 121(22). PMID: 26291519    Free PMC article.
Current Understanding of Circulating Tumor Cells - Potential Value in Malignancies of the Central Nervous System.
Lukasz A Adamczyk, Hannah Williams, +5 authors, Kathreena M Kurian.
Front Neurol, 2015 Sep 01; 6. PMID: 26322014    Free PMC article.
Review.
Prognosis for Survival of Young Women with Breast Cancer by Quantitative p53 Immunohistochemistry.
David E Axelrod, Kinsuk Shah, Qifeng Yang, Bruce G Haffty.
Cancer Clin Oncol, 2012 Jan 01; 1(1). PMID: 26322145    Free PMC article.
Personalized Medicine: Genomics Trials in Oncology.
Daniel F Hayes, Anne F Schott.
Trans Am Clin Climatol Assoc, 2015 Sep 04; 126. PMID: 26330667    Free PMC article.
Review.
Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer.
Maria Karsten, Michelle Stempel, +2 authors, Tari A King.
Ann Surg Oncol, 2015 Sep 06; 23(2). PMID: 26340863    Free PMC article.
Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
Miguel Angel Pavón, Irene Arroyo-Solera, +11 authors, Ramón Mangues.
Oncotarget, 2015 Sep 12; 6(30). PMID: 26359694    Free PMC article.
Serum Tumor Marker Use in Patients With Advanced Solid Tumors.
Melissa K Accordino, Jason D Wright, +11 authors, Dawn L Hershman.
J Oncol Pract, 2015 Sep 17; 12(1). PMID: 26374862    Free PMC article.
Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma.
L Rossi, E Laas, +6 authors, F Reyal.
Br J Cancer, 2015 Sep 18; 113(7). PMID: 26379080    Free PMC article.
MiRNA-29c regulates cell growth and invasion by targeting CDK6 in bladder cancer.
Xin Zhao, Junliang Li, +3 authors, Denglong Wu.
Am J Transl Res, 2015 Sep 24; 7(8). PMID: 26396669    Free PMC article.
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, +28 authors, George W Sledge.
N Engl J Med, 2015 Sep 29; 373(21). PMID: 26412349    Free PMC article.
Highly Cited.
Adoption of Gene Expression Profiling for Breast Cancer in US Oncology Practice for Women Younger Than 65 Years.
Suzanne C O'Neill, Claudine Isaacs, +8 authors, Arnold L Potosky.
J Natl Compr Canc Netw, 2015 Oct 21; 13(10). PMID: 26483061    Free PMC article.
St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study.
M Soares, J Correia, M C Peleteiro, F Ferreira.
Tumour Biol, 2015 Oct 22; 37(3). PMID: 26486327
Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.
Michèl Schummer, Jason Thorpe, +4 authors, Nicole Urban.
PLoS One, 2015 Nov 14; 10(11). PMID: 26565788    Free PMC article.
Adjuvant Chemotherapy Use and Health Care Costs After Introduction of Genomic Testing in Breast Cancer.
Andrew J Epstein, Yu-Ning Wong, +6 authors, Peter W Groeneveld.
J Clin Oncol, 2015 Nov 26; 33(36). PMID: 26598749    Free PMC article.
A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer.
Michael D Alvarado, Che Prasad, +5 authors, Christos J Markopoulos.
Adv Ther, 2015 Nov 28; 32(12). PMID: 26610383    Free PMC article.
Ki-67 and caspase expression in breast carcinoma: does variance in locational sampling exist?
Filinte Deniz, Kaymakci Dilek, +2 authors, Kaya Handan.
Int J Clin Exp Pathol, 2015 Dec 01; 8(9). PMID: 26617854    Free PMC article.
Genetic variation in vitamin D-related genes and risk of breast cancer among women of European and East Asian descent.
Joy Shi, Anne Grundy, +8 authors, Kristan J Aronson.
Tumour Biol, 2015 Dec 04; 37(5). PMID: 26631034
Biomarkers in Breast Cancer - An Update.
M Schmidt, P A Fasching, M W Beckmann, H Kölbl.
Geburtshilfe Frauenheilkd, 2012 Sep 01; 72(9). PMID: 26640290    Free PMC article.
"OMIC" tumor markers for breast cancer: A review.
Naila Irum Hadi, Qamar Jamal.
Pak J Med Sci, 2015 Dec 10; 31(5). PMID: 26649025    Free PMC article.
Review.
Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies.
David Hicks, Patrizia Dell'Orto, +6 authors, Giuseppe Viale.
Appl Immunohistochem Mol Morphol, 2015 Dec 15; 25(5). PMID: 26657878    Free PMC article.
Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group*.
Genet Med, 2015 Dec 19; 18(8). PMID: 26681310
Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas.
Rajyasree Emmadi, Emanuele Canestrari, +4 authors, Elizabeth Wiley.
PLoS One, 2015 Dec 31; 10(12). PMID: 26717565    Free PMC article.
Integrated EpCAM-independent subtraction enrichment and iFISH strategies to detect and classify disseminated and circulating tumors cells.
Peter Ping Lin.
Clin Transl Med, 2016 Jan 01; 4(1). PMID: 26718583    Free PMC article.
Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer.
Kyueng-Whan Min, Dong-Hoon Kim, +14 authors, Kyoung Min Moon.
Virchows Arch, 2016 Jan 01; 468(4). PMID: 26719157
Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer.
Máire-Caitlín Casey, Karl J Sweeney, James Andrew Lawrence Brown, Michael J Kerin.
Int J Cancer, 2016 Jan 13; 139(1). PMID: 26756433    Free PMC article.
Review.
Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures.
Elizabete Bagordakis, Iris Sawazaki-Calone, +10 authors, Ricardo D Coletta.
Tumour Biol, 2016 Jan 15; 37(7). PMID: 26762409
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer.
Emilio Alba, Ana Lluch, +18 authors, Federico Rojo.
Oncologist, 2016 Jan 21; 21(2). PMID: 26786263    Free PMC article.
MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer.
Xin Zhao, Wei He, +4 authors, Denglong Wu.
Am J Transl Res, 2016 Jan 26; 7(11). PMID: 26807182    Free PMC article.
Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance.
Giuseppe Viale, Leen Slaets, +9 authors, Fatima Cardoso.
Breast Cancer Res Treat, 2016 Jan 29; 155(3). PMID: 26820652    Free PMC article.
Study design requirements for RNA sequencing-based breast cancer diagnostics.
Arvind Singh Mer, Daniel Klevebring, Henrik Grönberg, Mattias Rantalainen.
Sci Rep, 2016 Feb 03; 6. PMID: 26830453    Free PMC article.
Molecular Imaging of Biomarkers in Breast Cancer.
Gary A Ulaner, Chris C Riedl, +3 authors, Wolfgang Weber.
J Nucl Med, 2016 Feb 03; 57 Suppl 1. PMID: 26834103    Free PMC article.
Review.
Quantum dots-based double imaging combined with organic dye imaging to establish an automatic computerized method for cancer Ki67 measurement.
Lin-Wei Wang, Ai-Ping Qu, +5 authors, Juan Liu.
Sci Rep, 2016 Feb 04; 6. PMID: 26839163    Free PMC article.
Notch1 Signaling Regulates the Aggressiveness of Differentiated Thyroid Cancer and Inhibits SERPINE1 Expression.
Xiao-Min Yu, Renata Jaskula-Sztul, +7 authors, Herbert Chen.
Clin Cancer Res, 2016 Feb 06; 22(14). PMID: 26847059    Free PMC article.
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Lyndsay N Harris, Nofisat Ismaila, +11 authors, American Society of Clinical Oncology.
J Clin Oncol, 2016 Feb 10; 34(10). PMID: 26858339    Free PMC article.
Highly Cited. Review.
Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives.
Meagan B Myers.
Pharmgenomics Pers Med, 2016 Feb 10; 9. PMID: 26858530    Free PMC article.
Review.
Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study.
Ilaria Massa, Oriana Nanni, +11 authors, Dino Amadori.
Oncol Lett, 2016 Feb 13; 11(1). PMID: 26870292    Free PMC article.
A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk Scores.
Tao Wan, B Nicolas Bloch, +5 authors, Anant Madabhushi.
Sci Rep, 2016 Feb 19; 6. PMID: 26887643    Free PMC article.
Circulating tumor cell technologies.
Meghaan M Ferreira, Vishnu C Ramani, Stefanie S Jeffrey.
Mol Oncol, 2016 Feb 22; 10(3). PMID: 26897752    Free PMC article.
Highly Cited. Review.
Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status.
Maria Soares, Rita Ribeiro, +4 authors, Fernando Ferreira.
Oncotarget, 2016 Feb 26; 7(14). PMID: 26909614    Free PMC article.
Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer.
Sławomir Ławicki, Edyta Katarzyna Głażewska, +2 authors, Maciej Szmitkowski.
Ann Lab Med, 2016 Feb 27; 36(3). PMID: 26915610    Free PMC article.
The current use and attitudes towards tumor genome sequencing in breast cancer.
I Gingras, A Sonnenblick, +7 authors, H A Azim.
Sci Rep, 2016 Mar 05; 6. PMID: 26931736    Free PMC article.
Postoperative elevation of CA15-3 due to pernicious anemia in a patient without evidence of breast cancer recurrence.
Yayoi Adachi, Toyone Kikumori, +7 authors, Yasuhiro Kodera.
Surg Case Rep, 2016 Mar 05; 1(1). PMID: 26943450    Free PMC article.
Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers.
Hyung Sun Kim, Seho Park, +6 authors, Byeong-Woo Park.
PLoS One, 2016 Mar 10; 11(3). PMID: 26954364    Free PMC article.
The impact of the 21-gene assay on adjuvant treatment decisions in oestrogen receptor-positive early breast cancer: a prospective study.
Anna Kuchel, Tim Robinson, +8 authors, Jeremy P Braybrooke.
Br J Cancer, 2016 Mar 10; 114(7). PMID: 26954715    Free PMC article.
Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer.
Sławomir Ławicki, Monika Zajkowska, +2 authors, Maciej Szmitkowski.
Onco Targets Ther, 2016 Mar 12; 9. PMID: 26966379    Free PMC article.
Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.
Tari A King, Jaclyn P Lyman, +17 authors, Clifford A Hudis.
J Clin Oncol, 2016 Mar 24; 34(20). PMID: 27001590    Free PMC article.
Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer.
Stefan Mereiter, Meritxell Balmaña, +2 authors, Celso A Reis.
Front Oncol, 2016 Mar 26; 6. PMID: 27014630    Free PMC article.
Review.
Identification of Apolipoprotein C-I Peptides as a Potential Biomarker and its Biological Roles in Breast Cancer.
Yadong Sun, Junjie Zhang, +5 authors, Jiaxiang Wang.
Med Sci Monit, 2016 Apr 08; 22. PMID: 27052600    Free PMC article.
Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy.
Chalanda N Evans, Noel T Brewer, +6 authors, Suzanne C O'Neill.
Breast Cancer Res Treat, 2016 Apr 10; 156(3). PMID: 27059031    Free PMC article.
Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.
Wenrui Hao, Avner Friedman.
PLoS One, 2016 Apr 15; 11(4). PMID: 27078836    Free PMC article.
A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease.
J Kiran Kumar, A C Aronsson, +5 authors, S Eriksson.
Tumour Biol, 2016 Oct 27; 37(9). PMID: 27079872    Free PMC article.
Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey.
Vahit Ozmen, Ajlan Atasoy, +7 authors, Pinar Saip.
Cureus, 2016 Apr 16; 8(3). PMID: 27081583    Free PMC article.
Underutilization of gene expression profiling for early-stage breast cancer in California.
Rosemary D Cress, Yingjia S Chen, +2 authors, Kenneth W Kizer.
Cancer Causes Control, 2016 Apr 22; 27(6). PMID: 27097910    Free PMC article.
Patient-Centered Communication for Discussing Oncotype DX Testing.
Megan C Roberts, Amy Bryson, +4 authors, Stephanie B Wheeler.
Cancer Invest, 2016 Apr 29; 34(5). PMID: 27124287    Free PMC article.
Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review.
Cristina Ligia Cebotaru, Elena Diana Olteanu, +2 authors, Viorica Nagy.
Clujul Med, 2016 May 07; 89(2). PMID: 27152069    Free PMC article.
Review.
MicroRNA-21 as a potential diagnostic biomarker for breast cancer patients: a pooled analysis of individual studies.
Ying Gao, Qiliang Cai, +5 authors, Yaogang Wang.
Oncotarget, 2016 May 07; 7(23). PMID: 27153564    Free PMC article.
Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer.
Melissa K Accordino, Jason D Wright, +4 authors, Dawn L Hershman.
J Clin Oncol, 2016 May 11; 34(24). PMID: 27161970    Free PMC article.
A Comparison of Fresh Frozen vs. Formalin-Fixed, Paraffin-Embedded Specimens of Canine Mammary Tumors via Branched-DNA Assay.
Florenza Lüder Ripoli, Annika Mohr, +5 authors, Ingo Nolte.
Int J Mol Sci, 2016 May 18; 17(5). PMID: 27187374    Free PMC article.
Circulating long non-coding RNAs in cancer: current status and future perspectives.
Peng Qi, Xiao-Yan Zhou, Xiang Du.
Mol Cancer, 2016 May 18; 15(1). PMID: 27189224    Free PMC article.
Highly Cited. Review.
Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells.
A Tachtsidis, L M McInnes, +2 authors, C M Saunders.
Clin Exp Metastasis, 2016 May 18; 33(6). PMID: 27189371    Free PMC article.
Review.
Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer.
Su Hyun Lee, Seunggyun Ha, +9 authors, Gi Jeong Cheon.
Eur J Nucl Med Mol Imaging, 2016 May 23; 43(9). PMID: 27209424
Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement.
Molly M Morgan, Brian P Johnson, +4 authors, David J Beebe.
Pharmacol Ther, 2016 May 25; 165. PMID: 27218886    Free PMC article.
Review.
Breast cancer multigene testing trends and impact on chemotherapy use.
G Thomas Ray, Jeanne Mandelblatt, +4 authors, Tracy A Lieu.
Am J Manag Care, 2016 Jun 09; 22(5). PMID: 27266581    Free PMC article.
How Does Managed Care Improve the Quality of Breast Cancer Care Among Medicare-Insured Minority Women?
Julie Smith-Gagen, Travis Loux, Chris Drake, Eliseo J Pérez-Stable.
J Racial Ethn Health Disparities, 2016 Jun 14; 3(3). PMID: 27294748
Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge.
Song Zhao, Yu Mei, +2 authors, Rong Ma.
PLoS One, 2016 Jun 22; 11(6). PMID: 27327081    Free PMC article.
Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis.
Stylianos Serghiou, Aikaterini Kyriakopoulou, John P A Ioannidis.
Mol Cancer, 2016 Jun 30; 15(1). PMID: 27352941    Free PMC article.
Highly Cited. Systematic Review.
Association between Ultrasound Features and the 21-Gene Recurrence Score Assays in Patients with Oestrogen Receptor-Positive, HER2-Negative, Invasive Breast Cancer.
Eun Young Chae, Woo Kyung Moon, +8 authors, Sei Hyun Ahn.
PLoS One, 2016 Jul 01; 11(6). PMID: 27362843    Free PMC article.
An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.
Jelle Wesseling, Corrado Tinterri, +16 authors, Pino Cusumano.
Virchows Arch, 2016 Jul 06; 469(3). PMID: 27377889
Diagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis.
Monika Zajkowska, Edyta Katarzyna Głażewska, +3 authors, Sławomir Ławicki.
Mediators Inflamm, 2016 Jul 23; 2016. PMID: 27445439    Free PMC article.
CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.
Brigitte Rack, Julia Jückstock, +15 authors, SUCCESS Study Group.
Tumour Biol, 2016 Aug 03; 37(10). PMID: 27481512
Real-Time qPCR-Based Detection of Circulating Tumor Cells from Blood Samples of Adjuvant Breast Cancer Patients: A Preliminary Study.
Ulrich Andergassen, Michael Zebisch, +6 authors, Udo Jeschke.
Breast Care (Basel), 2016 Aug 06; 11(3). PMID: 27493620    Free PMC article.
Breast carcinoma with an Oncotype Dx recurrence score <18: Rate of distant metastases in a large series with clinical follow-up.
Hannah Y Wen, Melissa Krystel-Whittemore, +7 authors, Edi Brogi.
Cancer, 2016 Aug 16; 123(1). PMID: 27526056    Free PMC article.
Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial.
Sarat Chandarlapaty, David Chen, +10 authors, Mary Ellen Moynahan.
JAMA Oncol, 2016 Aug 18; 2(10). PMID: 27532364    Free PMC article.
Highly Cited.
The Relationship Between Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Expression of Breast Cancer and the Retention Index in Dual Phase (18)F-FDG PET/CT.
Hansol Moon, Woo Chul Noh, +10 authors, Sang Moo Lim.
Nucl Med Mol Imaging, 2016 Aug 20; 50(3). PMID: 27540429    Free PMC article.
A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer.
Sirwan M Hadad, Lee B Jordan, +5 authors, Alastair M Thompson.
BMC Cancer, 2016 Sep 24; 16(1). PMID: 27658825    Free PMC article.
Co-expression of p16 and p53 characterizes aggressive subtypes of ductal intraepithelial neoplasia.
Charles Bechert, Jee-Yeon Kim, Trine Tramm, Fattaneh A Tavassoli.
Virchows Arch, 2016 Sep 25; 469(6). PMID: 27664050
Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
Lahong Zhang, Zhaojun Chen, +11 authors, Yun Yen.
Oncol Rep, 2016 Oct 26; 36(5). PMID: 27666119    Free PMC article.
A novel quantitative immunohistochemistry method for precise protein measurements directly in formalin-fixed, paraffin-embedded specimens: analytical performance measuring HER2.
Kristian Jensen, Rikke Krusenstjerna-Hafstrøm, +2 authors, Helene Derand.
Mod Pathol, 2016 Oct 22; 30(2). PMID: 27767098
Genome evolution in ductal carcinoma in situ: invasion of the clones.
Anna K Casasent, Mary Edgerton, Nicholas E Navin.
J Pathol, 2016 Nov 20; 241(2). PMID: 27861897    Free PMC article.
Review.
Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.
Kelly K Hunt, Cansu Karakas, +13 authors, Khandan Keyomarsi.
Clin Cancer Res, 2016 Nov 25; 23(12). PMID: 27881578    Free PMC article.
Is it feasible to detect epidermal growth factor receptor mutations in circulating tumor cells in nonsmall cell lung cancer?: A meta-analysis.
Yafang Liu, Ze Xing, +4 authors, Yong Song.
Medicine (Baltimore), 2016 Nov 29; 95(47). PMID: 27893656    Free PMC article.
Epidemiology of breast cancer: retrospective study in the Central African Republic.
Augustin Balekouzou, Ping Yin, +13 authors, Boniface Koffi.
BMC Public Health, 2016 Dec 08; 16(1). PMID: 27923361    Free PMC article.
Tumour biomarkers: homeostasis as a novel prognostic indicator.
Michela Falco, Giuseppe Palma, +7 authors, Claudio Arra.
Open Biol, 2016 Dec 09; 6(12). PMID: 27927793    Free PMC article.
Review.
Estimating the OncotypeDX score: validation of an inexpensive estimation tool.
Anne A Eaton, Catherine E Pesce, +5 authors, Mahmoud El-Tamer.
Breast Cancer Res Treat, 2016 Dec 09; 161(3). PMID: 27928699    Free PMC article.
Incorporate gene signature profiling into routine molecular testing.
Neng Chen.
Appl Transl Genom, 2013 Apr 11; 2. PMID: 27942443    Free PMC article.
Review.
MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration.
Gloria Bertoli, Claudia Cava, +5 authors, Isabella Castiglioni.
Breast Cancer Res Treat, 2016 Dec 22; 161(3). PMID: 28000015    Free PMC article.
Synaptonemal Complex Protein 3 Transcript Analysis in Breast Cancer.
Maryam Beigom Mobasheri, Reza Shirkoohi, Mohammad Hossein Modarressi.
Iran J Public Health, 2017 Jan 06; 45(12). PMID: 28053928    Free PMC article.
Prognostic significance of Ki67 in Chinese women diagnosed with ER+/HER2- breast cancers by the 2015 St. Gallen consensus classification.
Yue Hu, Ran Gu, +9 authors, Weijuan Jia.
BMC Cancer, 2017 Jan 08; 17(1). PMID: 28061893    Free PMC article.
Comparison of Core Needle Biopsy and Excision Specimens for the Accurate Evaluation of Breast Cancer Molecular Markers: a Report of 1003 Cases.
Jie Chen, Zu Wang, +6 authors, Juxiang Gou.
Pathol Oncol Res, 2017 Jan 12; 23(4). PMID: 28074330
Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples.
Anna Kazarian, Oleg Blyuss, +8 authors, John F Timms.
Br J Cancer, 2017 Jan 13; 116(4). PMID: 28081538    Free PMC article.
Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy.
Li-Kun Hou, Yu-Shui Ma, +13 authors, Da Fu.
PLoS One, 2017 Feb 01; 12(1). PMID: 28141816    Free PMC article.
Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications.
S De Placido, C De Angelis, +9 authors, G Arpino.
Br J Cancer, 2017 Feb 09; 116(6). PMID: 28170371    Free PMC article.
Parity association with clinicopathological factors in invasive breast cancer: a retrospective analysis.
Sandi Shen, Shizhen Zhong, +2 authors, Wenhua Huang.
Onco Targets Ther, 2017 Feb 09; 10. PMID: 28176944    Free PMC article.
Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy.
Bernhard Kiss, Alexander W Wyatt, +14 authors, Roland Seiler.
Sci Rep, 2017 Feb 17; 7. PMID: 28205537    Free PMC article.
Oncologist and organizational factors associated with variation in breast cancer multigene testing.
Tracy A Lieu, G Thomas Ray, +8 authors, Jeanne S Mandelblatt.
Breast Cancer Res Treat, 2017 Feb 23; 163(1). PMID: 28224383    Free PMC article.
Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients.
Daniella Klebaner, Stephen Hamilton-Dutoit, +11 authors, Ylva Hellberg.
PLoS One, 2017 Mar 17; 12(3). PMID: 28301514    Free PMC article.
Identification of novel SNPs in differentially expressed genes and its association with horn cancer of Bos indicus bullocks by next-generation sequencing.
P G Koringa, S J Jakhesara, D N Rank, C G Joshi.
3 Biotech, 2016 Jan 01; 6(1). PMID: 28330108    Free PMC article.
Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey.
Vahit Özmen, Ajlan Atasoy, +9 authors, Pınar Saip.
J Breast Health, 2016 Jan 01; 12(3). PMID: 28331745    Free PMC article.
Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
Yu Xu, Tai Qin, +7 authors, He Ren.
Int J Mol Sci, 2017 Mar 24; 18(4). PMID: 28333072    Free PMC article.
21-Gene recurrence score testing among Medicare beneficiaries with breast cancer in 2010-2013.
Julie A Lynch, Brygida Berse, Nicole Coomer, John Kautter.
Genet Med, 2017 Mar 24; 19(10). PMID: 28333918
SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer.
N L E Harris, C Vennin, +14 authors, D N Saunders.
Oncogene, 2017 Mar 28; 36(30). PMID: 28346421    Free PMC article.
Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65.
Suzanne C O'Neill, Claudine Isaacs, +8 authors, Arnold L Potosky.
Breast Cancer Res, 2017 Apr 01; 19(1). PMID: 28359319    Free PMC article.
Detection of Methylated Circulating DNA as Noninvasive Biomarkers for Breast Cancer Diagnosis.
Isabella Wai Yin Cheuk, Vivian Yvonne Shin, Ava Kwong.
J Breast Cancer, 2017 Apr 07; 20(1). PMID: 28382090    Free PMC article.
Review.
Reproducibility and Prognostic Potential of Ki-67 Proliferation Index when Comparing Digital-Image Analysis with Standard Semi-Quantitative Evaluation in Breast Cancer.
Balázs Ács, Lilla Madaras, +5 authors, Attila Marcell Szász.
Pathol Oncol Res, 2017 Apr 13; 24(1). PMID: 28401450
Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10).
Bernhard C Pestalozzi, Christoph Tausch, +17 authors, Swiss Group for Clinical Cancer Research (SAKK).
BMC Cancer, 2017 Apr 15; 17(1). PMID: 28407750    Free PMC article.
18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer.
Ana E Brito, Allan Santos, +8 authors, Elba Etchebehere.
Oncotarget, 2017 Apr 19; 8(22). PMID: 28415595    Free PMC article.
Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer.
Sung Gwe Ahn, Jae-Hoon Lee, +8 authors, Seung Il Kim.
PLoS One, 2017 Apr 19; 12(4). PMID: 28419166    Free PMC article.
Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
Wei Wu, Zhenzhen Zhang, +11 authors, Wei Zhang.
Oncotarget, 2017 Apr 21; 8(13). PMID: 28423493    Free PMC article.
Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer.
Luigi Cormio, Francesca Sanguedolce, +7 authors, Pantaleo Bufo.
Oncotarget, 2017 Apr 28; 8(15). PMID: 28445991    Free PMC article.
Detection of circulating tumor cells in patients with non-small cell lung cancer using a size-based platform.
Chung-Hee Sonn, Jong Ho Cho, +3 authors, Jhingook Kim.
Oncol Lett, 2017 Apr 30; 13(4). PMID: 28454457    Free PMC article.
Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis.
Ziqiang Lin, James Neiswender, +3 authors, Xiuying Hu.
Oncotarget, 2017 May 04; 8(16). PMID: 28460452    Free PMC article.
An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®.
Zsuzsanna Varga, Annette Lebeau, +18 authors, Giuseppe Viale.
Breast Cancer Res, 2017 May 12; 19(1). PMID: 28490348    Free PMC article.
High expression of PLA2G16 is associated with a better prognosis in HER2-positive breast cancer.
Xueli Yang, Zhengquan Zhang, +7 authors, Shunbin Xiong.
J Thorac Dis, 2017 May 20; 9(4). PMID: 28523155    Free PMC article.
Clinical utility of gene-expression signatures in early stage breast cancer.
Maryann Kwa, Andreas Makris, Francisco J Esteva.
Nat Rev Clin Oncol, 2017 Jun 01; 14(10). PMID: 28561071
Highly Cited. Review.
[Molecular biomarkers and prognostic factors for prostate cancer].
A Kretschmer, Y Tolkach, J Ellinger, G Kristiansen.
Urologe A, 2017 Jun 03; 56(7). PMID: 28573413
Review.
The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis.
Gulisa Turashvili, Edi Brogi, +4 authors, Hannah Y Wen.
Breast Cancer Res Treat, 2017 Jun 04; 165(1). PMID: 28577081    Free PMC article.
Chitotriosidase, a marker of innate immunity, is elevated in patients with primary breast cancer.
Mya Sanda Thein, Anita Kohli, +3 authors, Neal S Fedarko.
Cancer Biomark, 2017 Jun 07; 19(4). PMID: 28582842    Free PMC article.
Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer.
Rodrigo Goncalves, Katherine DeSchryver, +11 authors, Matthew J Ellis.
Breast Cancer Res Treat, 2017 Jun 15; 165(2). PMID: 28612227    Free PMC article.
The Potential for Circulating Tumor Cells in Pancreatic Cancer Management.
Michael Pimienta, Mouad Edderkaoui, Ruoxiang Wang, Stephen Pandol.
Front Physiol, 2017 Jun 20; 8. PMID: 28626429    Free PMC article.
Review.
Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3.0T DW-MRI: A potential predictor for an oncotype Dx test recurrence score.
Sunitha B Thakur, Manuela Durando, +5 authors, Elizabeth A Morris.
J Magn Reson Imaging, 2017 Jun 24; 47(2). PMID: 28640531    Free PMC article.
The effect of 14-3-3ζ expression on tamoxifen resistance and breast cancer recurrence: a Danish population-based study.
Jake E Thistle, Ylva Hellberg, +5 authors, Timothy L Lash.
Breast Cancer Res Treat, 2017 Jun 24; 165(3). PMID: 28643021    Free PMC article.
Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.
Giuseppe Merlino, Patrizia Miodini, +3 authors, Maria Grazia Daidone.
Mol Oncol, 2017 Jul 04; 11(10). PMID: 28672102    Free PMC article.
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.
Ian Krop, Nofisat Ismaila, +10 authors, Vered Stearns.
J Clin Oncol, 2017 Jul 12; 35(24). PMID: 28692382    Free PMC article.
Highly Cited.
Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.
Miguel Martín, José I Chacón, +19 authors, Silvia Antolín.
Oncologist, 2017 Jul 14; 22(11). PMID: 28701571    Free PMC article.
21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.
Gulisa Turashvili, Joanne F Chou, +5 authors, Hannah Y Wen.
Breast Cancer Res Treat, 2017 Jul 14; 166(1). PMID: 28702894    Free PMC article.
CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer.
Sung Hoon Sim, Chang-Dae Bae, +16 authors, Jungsil Ro.
PLoS One, 2017 Aug 05; 12(8). PMID: 28771517    Free PMC article.
Large-scale 3-dimensional quantitative imaging of tissues: state-of-the-art and translational implications.
Seth Winfree, Michael J Ferkowicz, +7 authors, Tarek M El-Achkar.
Transl Res, 2017 Aug 09; 189. PMID: 28784428    Free PMC article.
Review.
Analysis of blood markers for early breast cancer diagnosis.
J Bayo, M A Castaño, F Rivera, F Navarro.
Clin Transl Oncol, 2017 Aug 16; 20(4). PMID: 28808872
Finding the right balance between precision medicine and personalized care.
Finlay A McAlister, Andreas Laupacis, Paul W Armstrong.
CMAJ, 2017 Aug 23; 189(33). PMID: 28827437    Free PMC article.
Review.
Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung.
Sinead A Noonan, Tejas Patil, +8 authors, D Ross Camidge.
J Thorac Oncol, 2017 Aug 28; 13(1). PMID: 28843358    Free PMC article.
Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1.
Johannes Ettl, Evelyn Klein, +7 authors, Marion Kiechle.
PLoS One, 2017 Sep 07; 12(9). PMID: 28877230    Free PMC article.
Invasive Ductal Carcinoma Breast: How Neoadjuvant Chemotherapy Affects the Status of Estrogen Receptor, Progesterone Receptor and HER2/Neu-A Tertiary Care Centre Study.
Swasti Shubham, Pratibha Maan, Monika Singh, Minakshi Bhardwaj.
J Clin Diagn Res, 2017 Sep 13; 11(7). PMID: 28892901    Free PMC article.
Serum levels of urokinase-type plasminogen activator in healthy dogs and oncologic canine patients.
Sofia C Ramos, Augusto J de Matos, +4 authors, Andreia A Santos.
Vet World, 2017 Sep 19; 10(8). PMID: 28919683    Free PMC article.
Systematic Correlation Analyses of Circulating Tumor Cells with Clinical Variables and Tumor Markers in Lung Cancer Patients.
Xu Wang, Kewei Ma, +5 authors, Wei Li.
J Cancer, 2017 Sep 21; 8(15). PMID: 28928901    Free PMC article.
Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence.
Jian Yuan Goh, Min Feng, +19 authors, Qiang Yu.
Nat Med, 2017 Oct 03; 23(11). PMID: 28967919
Awareness and current knowledge of breast cancer.
Muhammad Akram, Mehwish Iqbal, Muhammad Daniyal, Asmat Ullah Khan.
Biol Res, 2017 Oct 04; 50(1). PMID: 28969709    Free PMC article.
Highly Cited. Review.
Cancer antigen 15-3, platelet distribution width, and fibrinogen in combination to distinguish breast cancer from benign breast disease in non-conclusive mammography patients.
Shuang Fu, Zhi-Yuan Yun, +6 authors, Kai-Jiang Yu.
Oncotarget, 2017 Oct 06; 8(40). PMID: 28978076    Free PMC article.
Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Wenzhe Li, Huailei Ma, +3 authors, Yanlian Yang.
Sci Rep, 2017 Oct 25; 7(1). PMID: 29062075    Free PMC article.
Highly Cited.
Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.
Guankui Wang, Halli Benasutti, +9 authors, Dmitri Simberg.
Colloids Surf B Biointerfaces, 2017 Oct 29; 161. PMID: 29080504    Free PMC article.
Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.
Joanna L Sylman, Annachiara Mitrugno, +3 authors, Owen J T McCarty.
Converg Sci Phys Oncol, 2017 Oct 31; 3(2). PMID: 29081989    Free PMC article.
Functionalized vertical GaN micro pillar arrays with high signal-to-background ratio for detection and analysis of proteins secreted from breast tumor cells.
Mun-Ki Choi, Gil-Sung Kim, +4 authors, Sang-Kwon Lee.
Sci Rep, 2017 Nov 04; 7(1). PMID: 29097674    Free PMC article.
Diffusion-weighted MRI characteristics associated with prognostic pathological factors and recurrence risk in invasive ER+/HER2- breast cancers.
Nita Amornsiripanitch, Vicky T Nguyen, +4 authors, Savannah C Partridge.
J Magn Reson Imaging, 2017 Nov 28; 48(1). PMID: 29178616    Free PMC article.
Increased expression of miR-155 and miR-222 is associated with lymph node positive status.
Vladimir Chernyy, Vladimir Pustylnyak, Vadim Kozlov, Lyudmila Gulyaeva.
J Cancer, 2018 Jan 02; 9(1). PMID: 29290778    Free PMC article.
21-gene recurrence assay in patients receiving intraoperative radiotherapy: are "favorable" characteristics a surrogate for low recurrence?
Bridget A Oppong, Surupa Sen Gupta, +6 authors, Shawna C Willey.
Gland Surg, 2018 Jan 06; 6(6). PMID: 29302485    Free PMC article.
Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.
Gulisa Turashvili, Edi Brogi, +4 authors, Hannah Y Wen.
BMC Cancer, 2018 Jan 07; 18(1). PMID: 29304773    Free PMC article.
VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin.
Yuhui Wang, Menglin Zhu, +5 authors, Xiaoqun Duan.
Molecules, 2018 Jan 11; 23(1). PMID: 29316690    Free PMC article.
Evaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer.
Sadr-Ul Shaheed, Catherine Tait, +3 authors, Chris Sutton.
Clin Proteomics, 2018 Jan 19; 15. PMID: 29344009    Free PMC article.
Review.
Elevation of serum CEA and CA15-3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients.
Yue Yang, Huijuan Zhang, +3 authors, Qingyuan Zhang.
Oncol Lett, 2018 Jan 19; 14(6). PMID: 29344201    Free PMC article.
Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I-III breast cancer: ER+/PR+, HER2- vs. triple-negative.
Lu Zhang, Qingzhao Yu, +5 authors, Tekeda Ferguson.
Breast Cancer Res Treat, 2018 Jan 26; 169(1). PMID: 29368311    Free PMC article.
Characterization of circulating tumor cells in newly diagnosed breast cancer.
Lu Xu, Songlin Jia, +8 authors, Yuan Sheng.
Oncol Lett, 2018 Feb 13; 15(2). PMID: 29434968    Free PMC article.
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer.
J Oncol Pract, 2007 Nov 01; 3(6). PMID: 29436954    Free PMC article.
An efficient biomarker panel for diagnosis of breast cancer using surface-enhanced laser desorption ionization time-of-flight mass spectrometry.
Turkan Yigitbasi, Gizem Calibasi-Kocal, +5 authors, Yasemin Baskin.
Biomed Rep, 2018 Feb 20; 8(3). PMID: 29456844    Free PMC article.
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.
Niaz Mahmood, Catalin Mihalcioiu, Shafaat A Rabbani.
Front Oncol, 2018 Feb 28; 8. PMID: 29484286    Free PMC article.
Highly Cited. Review.
Electroretinographic improvement after rituximab therapy in a patient with autoimmune retinopathy.
Gunay Uludag, Sumru Onal, +4 authors, Nil Molinas Mandel.
Am J Ophthalmol Case Rep, 2016 Mar 30; 2. PMID: 29503888    Free PMC article.
Expression of CK19, CD105 and CD146 are associated with early metastasis in patients with renal cell carcinoma.
Xiaojie Yang, Dong Zhang, +3 authors, Peng Zhang.
Oncol Lett, 2018 Mar 16; 15(4). PMID: 29541188    Free PMC article.
Identification of a novel human estrogen receptor-α splice variant able to enhance malignant biological behaviors of breast cancer cells.
Hua Zhu, Yue Huang, +5 authors, Zhenbo Feng.
Oncol Lett, 2018 Mar 20; 15(4). PMID: 29552176    Free PMC article.
Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Minghui Li, Yan Zhou, +6 authors, Shui Wang.
Breast Cancer Res Treat, 2018 Mar 21; 170(2). PMID: 29557526    Free PMC article.
Liquid biopsy provides new insights into gastric cancer.
Camila Tavares Uchôa Guimarães, Nina Nayara Ferreira Martins, +8 authors, Danielle Queiroz Calcagno.
Oncotarget, 2018 Mar 31; 9(19). PMID: 29599934    Free PMC article.
Review.
Histo-epidemiological profile of breast cancers among women in the Central African Republic: about 174 cases.
Augustin Balekouzou, Ping Yin, +9 authors, Boniface Koffi.
BMC Cancer, 2018 Apr 07; 18(1). PMID: 29621999    Free PMC article.
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives?
Navid Sobhani, Daniele Generali, +2 authors, Bruna Scaggiante.
World J Clin Oncol, 2018 Apr 14; 9(2). PMID: 29651384    Free PMC article.
Review.
Haploid genetic screens identify genetic vulnerabilities to microtubule-targeting agents.
Nora M Gerhards, Vincent A Blomen, +6 authors, Sven Rottenberg.
Mol Oncol, 2018 Apr 25; 12(6). PMID: 29689640    Free PMC article.
Expression of p27 and c-Myc by immunohistochemistry in breast ductal cancers in African American women.
Farhan Khan, Luisel J Ricks-Santi, +2 authors, Tammey Naab.
Ann Diagn Pathol, 2018 May 02; 34. PMID: 29715580    Free PMC article.
Use of CA15‑3 for screening breast cancer: An antibody‑lectin sandwich assay for detecting glycosylation of CA15‑3 in sera.
Jae Woong Choi, Byung-In Moon, +3 authors, Hong-Jin Kim.
Oncol Rep, 2018 May 12; 40(1). PMID: 29749490    Free PMC article.
Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients.
Xuan Li, Danian Dai, +3 authors, Weidong Wei.
Dis Markers, 2018 Jun 02; 2018. PMID: 29854028    Free PMC article.
Review.
Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA.
Martin Zaleski, Makbule Kobilay, +7 authors, Stefan Holdenrieder.
Oncotarget, 2018 Jun 02; 9(32). PMID: 29854296    Free PMC article.
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, +27 authors, George W Sledge.
N Engl J Med, 2018 Jun 05; 379(2). PMID: 29860917    Free PMC article.
Highly Cited.
Identification of endothelial selectin as a potential prognostic marker in breast cancer.
Wei Zhang, Zhichao Zuo, +3 authors, Danke Su.
Oncol Lett, 2018 Jun 22; 15(6). PMID: 29928363    Free PMC article.
Liquid biopsy in pancreatic cancer: the beginning of a new era.
Dipesh Kumar Yadav, Xueli Bai, +5 authors, Tingbo Liang.
Oncotarget, 2018 Jun 22; 9(42). PMID: 29928492    Free PMC article.
Review.
Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer.
Isaac Kim, Hee Jun Choi, +5 authors, Jeong Eon Lee.
J Breast Cancer, 2018 Jul 03; 21(2). PMID: 29963113    Free PMC article.
Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology.
Danielle M Bello, Christy Russell, +2 authors, Monica Morrow.
Ann Surg Oncol, 2018 Jul 04; 25(10). PMID: 29968028    Free PMC article.
The clinical application of tumor markers in the screening of malignancies and interstitial lung disease of dermatomyositis/polymyositis patients: A retrospective study.
Chong Hong Lim, Chih-Wei Tseng, +4 authors, Der-Yuan Chen.
SAGE Open Med, 2018 Jul 07; 6. PMID: 29977547    Free PMC article.
Elevated pre-surgical CA15-3: does it predict the short-term disease-free survival of breast cancer patients without distant metastasis?
Lakmini Kb Mudduwa, Gaya B Wijayaratne, +3 authors, Nimsha Liyanage.
Int J Womens Health, 2018 Jul 10; 10. PMID: 29983596    Free PMC article.
Failure of Ploidy and Proliferative Fraction to Predict Long-Term Outcome After Prostatectomy.
Gregory P Swanson, Wencong Chen, V O Speights.
World J Oncol, 2018 Jul 11; 9(3). PMID: 29988804    Free PMC article.
Concordance between Immunohistochemistry and Microarray Gene Expression Profiling for Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Statuses in Breast Cancer Patients in Lebanon.
Ghina B Fakhri, Reem S Akel, +3 authors, Arafat H Tfayli.
Int J Breast Cancer, 2018 Jul 17; 2018. PMID: 30009057    Free PMC article.
MircoRNA-1275 promotes proliferation, invasion and migration of glioma cells via SERPINE1.
Dong-Mei Wu, Shan Wang, +7 authors, Yuan-Lin Zheng.
J Cell Mol Med, 2018 Jul 20; 22(10). PMID: 30024092    Free PMC article.
Association of Metabolic, Inflammatory, and Tumor Markers With Circulating Tumor Cells in Metastatic Breast Cancer.
Ana Elisa Lohmann, Ryan J O Dowling, +9 authors, Martin C Chang.
JNCI Cancer Spectr, 2018 Jul 24; 2(2). PMID: 30035251    Free PMC article.
Breast Cancers of Special Histologic Subtypes Are Biologically Diverse.
Audree B Tadros, Hannah Y Wen, Monica Morrow.
Ann Surg Oncol, 2018 Aug 11; 25(11). PMID: 30094484    Free PMC article.
A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer.
Tanya T Kwan, Aditya Bardia, +15 authors, Shyamala Maheswaran.
Cancer Discov, 2018 Aug 15; 8(10). PMID: 30104333    Free PMC article.
6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer.
Benjamin J Buckley, Ashraf Aboelela, +13 authors, Michael J Kelso.
J Med Chem, 2018 Aug 22; 61(18). PMID: 30130401    Free PMC article.
Determination of the prognostic value of preoperative CA15-3 and CEA in predicting the prognosis of young patients with breast cancer.
Xuan Li, Danian Dai, +3 authors, Weidong Wei.
Oncol Lett, 2018 Sep 15; 16(4). PMID: 30214602    Free PMC article.
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis.
Yixiao Feng, Mia Spezia, +15 authors, Guosheng Ren.
Genes Dis, 2018 Sep 28; 5(2). PMID: 30258937    Free PMC article.
Highly Cited. Review.
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project.
Giacomo Pelizzari, Grazia Arpino, +8 authors, Fabio Puglisi.
BMC Cancer, 2018 Sep 29; 18(1). PMID: 30261866    Free PMC article.
Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers.
Wenyong Tan, Ming Yang, +2 authors, Weixi Shen.
Cancer Manag Res, 2018 Oct 24; 10. PMID: 30349367    Free PMC article.
Review.
Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer.
Monika Zajkowska, Emilia Lubowicka, +3 authors, Sławomir Ławicki.
Pathol Oncol Res, 2018 Nov 06; 25(4). PMID: 30387014    Free PMC article.
Factors Associated With Follow-Up Care Among Women With Early-Stage Breast Cancer.
Farah F Quyyumi, Jason D Wright, +5 authors, Dawn L Hershman.
J Oncol Pract, 2018 Nov 09; 15(1). PMID: 30407882    Free PMC article.
Characteristics and prognostic values of traditional pathological parameters and advanced molecular subtypes in women in Beijing with operable breast cancer: a retrospective analysis.
Qin Li, Li Li, +5 authors, Bangwei Cao.
BMJ Open, 2018 Nov 11; 8(11). PMID: 30413499    Free PMC article.
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer.
Charles E Geyer, Gong Tang, +8 authors, Norman Wolmark.
NPJ Breast Cancer, 2018 Nov 21; 4. PMID: 30456299    Free PMC article.
Correlation of Serum Levels of Urokinase Activation Plasminogen (uPA) and Its Inhibitor (PAI-1) with Hormonal and HER-2 Status in the Early Invasive Breast Cancer.
Sadat Pusina.
Med Arch, 2018 Dec 14; 72(5). PMID: 30524164    Free PMC article.
Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma.
Xiao He, Xiaoling Xu, Guanxia Zhu, Hong Ye.
Medicine (Baltimore), 2019 Mar 01; 98(9). PMID: 30817615    Free PMC article.
Panoptic View of Prognostic Models for Personalized Breast Cancer Management.
Geetanjali Saini, Karuna Mittal, +3 authors, Ritu Aneja.
Cancers (Basel), 2019 Sep 11; 11(9). PMID: 31500225    Free PMC article.
Review.
Diffusion-Weighted Imaging of Breast Cancer: Correlation of the Apparent Diffusion Coefficient Value with Pathologic Prognostic Factors.
Şehnaz Tezcan, Nihal Uslu, +2 authors, Tugan Tezcaner.
Eur J Breast Health, 2019 Oct 18; 15(4). PMID: 31620686    Free PMC article.
External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China.
Tianjie Pu, Ruohong Shui, +6 authors, China Anticancer Association Professional Committee of Tumour Pathology.
BMC Cancer, 2019 Oct 24; 19(1). PMID: 31640622    Free PMC article.
Deciphering HER2 Breast Cancer Disease: Biological and Clinical Implications.
Ana Godoy-Ortiz, Alfonso Sanchez-Muñoz, +4 authors, Emilio Alba.
Front Oncol, 2019 Nov 19; 9. PMID: 31737566    Free PMC article.
Review.
Plasma Level Of miR-21 And miR-451 In Primary And Recurrent Breast Cancer Patients.
Maryam Motamedi, Morteza Hashemzadeh Chaleshtori, Sorayya Ghasemi, Fariborz Mokarian.
Breast Cancer (Dove Med Press), 2019 Nov 22; 11. PMID: 31749630    Free PMC article.
Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice.
Douglas Grossman, Caroline C Kim, +6 authors, Susan M Swetter.
Melanoma Manag, 2019 Dec 25; 6(4). PMID: 31871621    Free PMC article.
Review.
Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer.
Clemens Hufnagl, Michael Leisch, +9 authors, Alexander Egle.
Oncol Lett, 2020 Jan 23; 19(2). PMID: 31966080    Free PMC article.
Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer.
Young-Joon Kang, Han-Byoel Lee, +7 authors, Wonshik Han.
J Oncol, 2020 Jan 25; 2019. PMID: 31975992    Free PMC article.
Breast Cancer Recurrence Risk Assessment: Is Non-Invasive Monitoring an Option?
Elisa M Schunkert, Wanzhou Zhao, Kurt Zänker.
Biomed Hub, 2018 Nov 01; 3(3). PMID: 31988964    Free PMC article.
Review.
A Circulating miRNA Signature for Stratification of Breast Lesions among Women with Abnormal Screening Mammograms.
Sau Yeen Loke, Prabhakaran Munusamy, +18 authors, Ann Siew Gek Lee.
Cancers (Basel), 2019 Nov 27; 11(12). PMID: 31769433    Free PMC article.
The utility of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta-analysis.
Salma Naheed, Chloe Holden, +4 authors, Giuseppe Pelosi.
BMJ Open, 2019 Aug 26; 9(8). PMID: 31446421    Free PMC article.
Indications for prognostic gene expression profiling in early breast cancer.
Erin F Cobain, Daniel F Hayes.
Curr Treat Options Oncol, 2015 May 02; 16(5). PMID: 25929335
Review.
Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria.
Kelsey H Natsuhara, Katya Losk, +7 authors, Rachel A Freedman.
Oncologist, 2018 Aug 05; 24(5). PMID: 30076279    Free PMC article.
Evaluating HER2 Gene Amplification Using Chromogenic In Situ Hybridization (CISH) Method In Comparison To Immunohistochemistry Method in Breast Carcinoma.
Hadi Atabati, Amir Raoofi, Abdollah Amini, Reza Masteri Farahani.
Open Access Maced J Med Sci, 2018 Dec 19; 6(11). PMID: 30559846    Free PMC article.
Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies.
Zhenlong Ye, Yongmei Ding, +9 authors, Qijun Qian.
Cancer Biol Ther, 2018 Dec 24; 20(4). PMID: 30572767    Free PMC article.
Impact of biomarkers and genetic profiling on breast cancer prognostication: A comparative analysis of the 8th edition of breast cancer staging system.
Esther C Yoon, Christopher Schwartz, +3 authors, Farbod Darvishian.
Breast J, 2019 Jun 15; 25(5). PMID: 31197914    Free PMC article.
Assessment of ERBB2 and TOP2α gene status and expression profile in feline mammary tumors: findings and guidelines.
Daniela Ferreira, Maria Soares, +3 authors, Raquel Chaves.
Aging (Albany NY), 2019 Jul 14; 11(13). PMID: 31301170    Free PMC article.
Human-specific RNA analysis shows uncoupled epithelial-mesenchymal plasticity in circulating and disseminated tumour cells from human breast cancer xenografts.
Anthony Tachtsidis, Anh Viet-Phuong Le, +5 authors, Erik W Thompson.
Clin Exp Metastasis, 2019 Jun 14; 36(4). PMID: 31190270
Smartphone Biosensor System with Multi-Testing Unit Based on Localized Surface Plasmon Resonance Integrated with Microfluidics Chip.
Zhiyuan Fan, Zhaoxin Geng, +4 authors, Hongda Chen.
Sensors (Basel), 2020 Jan 17; 20(2). PMID: 31941128    Free PMC article.
The emerging role of circulating tumor cells in cancer management.
Xue-Yao Li, Man Dong, +4 authors, Gang-Yang Wang.
Am J Transl Res, 2020 Mar 21; 12(2). PMID: 32194887    Free PMC article.
Review.
HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy.
Georgios Moustakas, Spyridon Kampantais, +3 authors, Georgios Dimitriadis.
J Int Med Res, 2020 Jan 16; 48(1). PMID: 31937176    Free PMC article.
Combination diagnosis with elastography strain ratio and molecular markers effectively improves the diagnosis rate of small breast cancer and lymph node metastasis.
Yi Hao, Guanghui Ren, +6 authors, Xia Guo.
Quant Imaging Med Surg, 2020 Apr 10; 10(3). PMID: 32269928    Free PMC article.
Clinical significance of circulating tumor cells in patients with locally advanced head and neck squamous cell carcinoma.
Kun Liu, Nanxiang Chen, +3 authors, Xinxin Zhang.
Oncol Rep, 2020 Apr 24; 43(5). PMID: 32323844    Free PMC article.
Digital quantification of KI-67 in breast cancer.
María Del Rosario Taco Sanchez, Teresa Soler-Monsó, +7 authors, Xavier Matias-Guiu.
Virchows Arch, 2018 Nov 23; 474(2). PMID: 30465110
Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer.
Mark Gray, James Meehan, +5 authors, David Argyle.
Front Oncol, 2020 May 16; 10. PMID: 32411603    Free PMC article.
Review.
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer.
Florian Clatot, Anne Perdrix, +16 authors, Frédéric Di Fiore.
Breast Cancer Res, 2020 May 30; 22(1). PMID: 32466779    Free PMC article.
Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ.
Koji Takada, Shinichiro Kashiwagi, +8 authors, Masaichi Ohira.
BMC Cancer, 2020 Jun 05; 20(1). PMID: 32493410    Free PMC article.
Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles.
Yumiko Koi, Yasuhiro Tsutani, +11 authors, Hidetoshi Tahara.
Cancer Sci, 2020 Mar 28; 111(6). PMID: 32215990    Free PMC article.
The age of paraffin block influences biomarker levels in archival breast cancer samples.
Hong Chen, Qing-Qing Fang, Bo Wang.
Oncol Lett, 2020 Jun 23; 20(1). PMID: 32565978    Free PMC article.
A comparison of landmark methods and time-dependent ROC methods to evaluate the time-varying performance of prognostic markers for survival outcomes.
Aasthaa Bansal, Patrick J Heagerty.
Diagn Progn Res, 2019 Aug 02; 3. PMID: 31367681    Free PMC article.
Correlation between salivary and serum CA15-3 concentrations in patients with breast cancer.
Daniele Xavier Assad, Elisa Cançado Porto Mascarenhas, +6 authors, Eliete Neves Silva Guerra.
Mol Clin Oncol, 2020 Jul 28; 13(2). PMID: 32714539    Free PMC article.
Clinical outcome of adjuvant radiotherapy for squamous cell carcinoma of the breast; a multicenter retrospective cohort study.
Mami Ogita, Kenshiro Shiraishi, +6 authors, Keiichi Nakagawa.
Breast, 2020 May 30; 52. PMID: 32470819    Free PMC article.
N-Alkylisatin-Loaded Liposomes Target the Urokinase Plasminogen Activator System in Breast Cancer.
Lisa Belfiore, Darren N Saunders, Marie Ranson, Kara L Vine.
Pharmaceutics, 2020 Jul 11; 12(7). PMID: 32645963    Free PMC article.
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
Caroline Rousseau, David M Goldenberg, +17 authors, Françoise Kraeber-Bodéré.
J Nucl Med, 2020 Mar 15; 61(8). PMID: 32169921    Free PMC article.
Comparative Analysis of the Development of Acquired Radioresistance in Canine and Human Mammary Cancer Cell Lines.
Mark Gray, Arran K Turnbull, +4 authors, David J Argyle.
Front Vet Sci, 2020 Aug 28; 7. PMID: 32851022    Free PMC article.
Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience.
Michela Palleschi, Roberta Maltoni, +16 authors, Sara Bravaccini.
Diagnostics (Basel), 2020 Aug 14; 10(8). PMID: 32784518    Free PMC article.
An individual reference limit of the serum CEA-TPA-CA 15-3 tumor marker panel in the surveillance of asymptomatic women following surgery for primary breast cancer.
Andrea Nicolini, Angelo Carpi, +4 authors, Michael J Duffy.
Cancer Manag Res, 2018 Dec 28; 10. PMID: 30588093    Free PMC article.
Ki-67 index value and progesterone receptor status can predict prognosis and suitable treatment in node-negative breast cancer patients with estrogen receptor-positive and HER2-negative tumors.
Nobuyuki Arima, Reiki Nishimura, +5 authors, Yasuo Toyozumi.
Oncol Lett, 2019 Jan 19; 17(1). PMID: 30655808    Free PMC article.
The novel sugar transporter SLC50A1 as a potential serum-based diagnostic and prognostic biomarker for breast cancer.
Yu Wang, Yao Shu, Congyang Gu, Yu Fan.
Cancer Manag Res, 2019 Jan 31; 11. PMID: 30697078    Free PMC article.
Tissue Expression of Prohibition-I and It's Relationship With Prognostic Factors in Breast Cancer.
Hossein Javid, Isaac Hashemy, +3 authors, Farnaz Zahedi Avval.
Iran J Pathol, 2019 Jan 31; 13(2). PMID: 30697295    Free PMC article.
21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving Surgery.
San-Gang Wu, Wen-Wen Zhang, +4 authors, Zhen-Yu He.
Front Oncol, 2019 Feb 15; 9. PMID: 30761267    Free PMC article.
High Expression B3GAT3 Is Related with Poor Prognosis of Liver Cancer.
Yan-Li Zhang, Chao Ding, Lei Sun.
Open Med (Wars), 2019 Mar 09; 14. PMID: 30847403    Free PMC article.
Association Analysis of Deep Genomic Features Extracted by Denoising Autoencoders in Breast Cancer.
Qian Liu, Pingzhao Hu.
Cancers (Basel), 2019 Apr 10; 11(4). PMID: 30959966    Free PMC article.
Computational Methods for the Discovery of Metabolic Markers of Complex Traits.
Michael Y Lee, Ting Hu.
Metabolites, 2019 Apr 17; 9(4). PMID: 30987289    Free PMC article.
Review.
Overexpression of ASPM, CDC20, and TTK Confer a Poorer Prognosis in Breast Cancer Identified by Gene Co-expression Network Analysis.
Jianing Tang, Mengxin Lu, +6 authors, Gaosong Wu.
Front Oncol, 2019 May 21; 9. PMID: 31106147    Free PMC article.
Association between Ki-67 expression and clinicopathological features in prognosis of breast cancer: A retrospective cohort study.
Hosein Kamranzadeh, Reza Manouchehri Ardekani, +4 authors, Nasrollah Maleki.
J Res Med Sci, 2019 May 31; 24. PMID: 31143231    Free PMC article.
PREDICTIVE CIRCULATING MARKERS FOR ANTHRACYCLINE CHEMOTHERAPY IN NON-METASTATIC BREAST CANCER.
I Botnariuc, S M Ilie, +3 authors, R M Anghel.
Acta Endocrinol (Buchar), 2017 Apr 01; 13(2). PMID: 31149175    Free PMC article.
Review.
Clinical analysis of 21-gene recurrence score test in hormone receptor-positive early-stage breast cancer.
Lizhe Zhu, Nan Ma, +5 authors, Yu Ren.
Oncol Lett, 2019 Jun 13; 17(6). PMID: 31186766    Free PMC article.
Increased Soluble CrkL in Serum of Breast Cancer Patients Is Associated with Advanced Disease.
Srimeenakshi Srinivasan, Biana Godin.
Cancers (Basel), 2019 Jul 22; 11(7). PMID: 31323992    Free PMC article.
Patterns of supraclavicular area failure after mastectomy in breast cancer patients: implications for target volume delineation.
Pei-Cheng Lin, Xi-Jin Lin, +6 authors, Jun-Xin Wu.
J Int Med Res, 2020 Sep 18; 48(9). PMID: 32938273    Free PMC article.
Targeting triple-negative breast cancers with the Smac-mimetic birinapant.
Najoua Lalaoui, Delphine Merino, +17 authors, John Silke.
Cell Death Differ, 2020 Apr 29; 27(10). PMID: 32341449    Free PMC article.
Integration the biologic factors into the staging of breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
Chen-Lu Lian, Xiao-Yang Cai, +3 authors, San-Gang Wu.
J Cancer, 2020 Oct 31; 11(23). PMID: 33123274    Free PMC article.
Non-Invasive Biomarkers for Early Detection of Breast Cancer.
Jiawei Li, Xin Guan, +5 authors, Dong-Xu Liu.
Cancers (Basel), 2020 Oct 01; 12(10). PMID: 32992445    Free PMC article.
Review.
Integrated Multiparametric Radiomics and Informatics System for Characterizing Breast Tumor Characteristics with the OncotypeDX Gene Assay.
Michael A Jacobs, Christopher B Umbricht, +5 authors, Antonio C Wolff.
Cancers (Basel), 2020 Oct 01; 12(10). PMID: 32992569    Free PMC article.
Diagnostic value of serum HER2 levels in breast cancer: a systematic review and meta-analysis.
Amir Shamshirian, Amir Reza Aref, +7 authors, Reza Alizadeh-Navaei.
BMC Cancer, 2020 Nov 02; 20(1). PMID: 33129287    Free PMC article.
Patient and physician factors associated with Oncotype DX and adjuvant chemotherapy utilization for breast cancer patients in New Hampshire, 2010-2016.
Thomas M Schwedhelm, Judy R Rees, +4 authors, Erika L Moen.
BMC Cancer, 2020 Sep 05; 20(1). PMID: 32883270    Free PMC article.
Performance of Automated Dissection on Formalin-Fixed Paraffin-Embedded Tissue Sections for the 21-Gene Recurrence Score Assay.
Peng Qi, Qian-Ming Bai, +2 authors, Xiao-Yan Zhou.
Technol Cancer Res Treat, 2020 Oct 20; 19. PMID: 33073677    Free PMC article.
Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study.
Yoshiki Mikami, Takayuki Ueno, +6 authors, Hironobu Sasano.
Cancer Sci, 2013 Aug 03; 104(11). PMID: 23905924    Free PMC article.
CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up.
T Dan, S M Hewitt, +10 authors, N L Simone.
Breast Cancer Res Treat, 2013 Nov 28; 143(1). PMID: 24276281    Free PMC article.
Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer.
Naoki Niikura, Takayuki Iwamoto, +9 authors, Yutaka Tokuda.
Cancer Sci, 2012 Apr 28; 103(8). PMID: 22537114    Free PMC article.
ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.
Megan C Roberts, Amy Bryson, +4 authors, Stephanie B Wheeler.
Int J Technol Assess Health Care, 2016 Dec 14; 32(5). PMID: 27958190    Free PMC article.
18F-AlF Labeled Peptide and Protein Conjugates as Positron Emission Tomography Imaging Pharmaceuticals.
Krishan Kumar, Arijit Ghosh.
Bioconjug Chem, 2018 Feb 22; 29(4). PMID: 29463084    Free PMC article.
Review.
A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor‒Positive, Human Epidermal Growth Factor 2 (HER2)‒Negative Breast Cancer.
Sae Byul Lee, Junetae Kim, +8 authors, Kyung Hae Jung.
Cancer Res Treat, 2018 Nov 06; 51(3). PMID: 30384581    Free PMC article.
Clinical target sequencing for precision medicine of breast cancer.
Junko Tsuchida, Jami Rothman, +3 authors, Toshifumi Wakai.
Int J Clin Oncol, 2019 Jan 04; 24(2). PMID: 30604156
Review.
Secreted Frizzled-Related Protein 2 Is Associated with Disease Progression and Poor Prognosis in Breast Cancer.
Chumei Huang, Zhuangjian Ye, +4 authors, Laisheng Li.
Dis Markers, 2019 Apr 05; 2019. PMID: 30944668    Free PMC article.
Monitoring Breast Cancer Response to Treatment Using Stokes Shift Spectroscopy of Blood Plasma.
Krishnamoorthy Chithra, Prakasarao Aruna, +2 authors, Singaravelu Ganesan.
J Fluoresc, 2019 Jun 13; 29(3). PMID: 31187405
Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer.
Yingjie Chen, Zhipeng Yang, +2 authors, Chuanxin Wang.
BMC Cancer, 2019 Jul 05; 19(1). PMID: 31269908    Free PMC article.
Is Routine Recurrence Score Testing in Patients Older than 70 Years of Age Warranted? An Evaluation of the National Cancer Database After TAILORx.
Rachel M Lee, Jeffrey M Switchenko, +3 authors, Preeti D Subhedar.
Ann Surg Oncol, 2019 Jul 26; 26(10). PMID: 31342377    Free PMC article.
Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters.
Atif Ali Hashmi, Kashif Ali Hashmi, +7 authors, Amir Khan.
BMC Res Notes, 2019 Sep 25; 12(1). PMID: 31547858    Free PMC article.
Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning.
Joon Ho Choi, Hyun-Ah Kim, +10 authors, Sang-Keun Woo.
Sci Rep, 2020 Dec 05; 10(1). PMID: 33273490    Free PMC article.
Targeting Stereotactic Body Radiotherapy on Metabolic PET- and Immuno-PET-Positive Vertebral Metastases.
Baptiste Pichon, Caroline Rousseau, +9 authors, Stéphane Supiot.
Biomedicines, 2020 Dec 03; 8(12). PMID: 33260610    Free PMC article.
Insights into Bioinformatic Applications for Glycosylation: Instigating an Awakening towards Applying Glycoinformatic Resources for Cancer Diagnosis and Therapy.
Manikandan Muthu, Sechul Chun, +4 authors, Jae-Wook Oh.
Int J Mol Sci, 2020 Dec 12; 21(24). PMID: 33302373    Free PMC article.
Review.
Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer.
Anna E M Bastiaansen, A Mieke Timmermans, +9 authors, Martijn M vanDuijn.
Sci Rep, 2020 Dec 20; 10(1). PMID: 33339858    Free PMC article.
The lingering mysteries of metastatic recurrence in breast cancer.
Alessandra I Riggio, Katherine E Varley, Alana L Welm.
Br J Cancer, 2020 Nov 27; 124(1). PMID: 33239679    Free PMC article.
Review.
Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer.
Milica Nedeljković, Nasta Tanić, +2 authors, Nikola Tanić.
Breast Cancer, 2021 Jan 10;. PMID: 33420675
Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer.
Yoon Ming Chin, Yoko Takahashi, +7 authors, Siew-Kee Low.
Cancer Sci, 2020 Oct 20; 112(1). PMID: 33075187    Free PMC article.
Common plasma protein marker LCAT in aggressive human breast cancer and canine mammary tumor.
Hyoung-Min Park, HuiSu Kim, +3 authors, Je-Yoel Cho.
BMB Rep, 2020 Dec 11; 53(12). PMID: 33298249    Free PMC article.
MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts.
Noemi Eiro, Sandra Cid, +6 authors, Francisco J Vizoso.
Int J Mol Sci, 2021 Jan 06; 22(1). PMID: 33396463    Free PMC article.
Serum MACC-1: a new biomarker for breast cancer.
Meraj Ahmed, Mohammad Aslam.
Oncotarget, 2021 Jan 06; 11(48). PMID: 33400729    Free PMC article.
Factors That Predict Biological Aggressiveness in Estrogen Receptor-Positive / Human Epidermal Growth Factor Receptor 2-Negative / Lymph Node-Negative Breast Cancer.
Lauren E Arthur, Ashley H McMann, +4 authors, Ralph L Corsetti.
Ochsner J, 2021 Jan 08; 20(4). PMID: 33408575    Free PMC article.
Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial.
Dena Firouzabadi, Amirreza Dehghanian, +2 authors, Abdolrasoul Talei.
BMC Cancer, 2021 Jan 13; 21(1). PMID: 33430808    Free PMC article.
Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer.
Siqi Bao, Ting Hu, +7 authors, Meng Zhou.
J Nanobiotechnology, 2021 Jan 14; 19(1). PMID: 33436002    Free PMC article.
Racial/ethnic differences in average CA125 and CA15.3 values and its correlates among postmenopausal women in the USA.
Naoko Sasamoto, Allison F Vitonis, +3 authors, Daniel W Cramer.
Cancer Causes Control, 2021 Jan 20; 32(3). PMID: 33462738    Free PMC article.
Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center.
Katya Losk, Rachel A Freedman, +7 authors, Tari A King.
Breast Cancer Res Treat, 2020 Sep 18; 185(1). PMID: 32939592
All-Cause and Cardiovascular Disease Mortality Among Breast Cancer Survivors in CLUE II, a Long-Standing Community-Based Cohort.
Cody Ramin, Marcy L Schaeffer, +4 authors, Kala Visvanathan.
J Natl Cancer Inst, 2020 Jul 08; 113(2). PMID: 32634223    Free PMC article.
Normalization of Elevated Tumor Marker CA27-29 After Bilateral Lung Transplantation in a Patient With Breast Cancer and Idiopathic Pulmonary Fibrosis.
Mehmet Sitki Copur, Julie Marie Wurdeman, +3 authors, David Crockett.
Oncol Res, 2017 Dec 13; 26(3). PMID: 29229020    Free PMC article.
A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling.
Ainhoa Arana Echarri, Mark Beresford, +6 authors, James E Turner.
Front Immunol, 2021 Feb 19; 11. PMID: 33597950    Free PMC article.
Review.
Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score.
Michelle Zhang, Meredith Sadinski, +5 authors, Elizabeth J Sutton.
Front Oncol, 2021 Feb 23; 10. PMID: 33614481    Free PMC article.